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ABSTRACT 
ROLE OF NON-MUSCLE MYOSIN II AND CALCIUM IN 
ZEBRAFISH MIDBRAIN-HINDBRAIN BOUNDARY 
MORPHOGENESIS 
 
by 
Srishti Upasana Sahu 
The University of Wisconsin-Milwaukee, 2015 
Under the Supervision of Dr. Jennifer H. Gutzman, Ph.D. 
 
Elucidating the molecular mechanisms that play a role in cellular morphogenesis 
is critical to our understanding of brain development and function. The midbrain-
hindbrain boundary (MHB) is one of the first folds in the vertebrate embryonic brain 
and is highly conserved across species. We used the zebrafish MHB as a model 
for determining the molecular mechanisms that regulate these cell shape changes. 
Cellular morphogenesis is tightly regulated by signaling pathways that rearrange 
the cytoskeleton and produce mechanical forces that enable changes in cell and 
tissue morphology. The generation of force within a cell often depends on motor 
proteins, particularly non-muscle myosins (NMII). We found that non-muscle 
myosin IIA (NMIIA) regulates cell length at the MHBC, while NMIIB regulates cell 
width throughout the MHB region. The novel discovery of distinct roles for the NMII 
proteins leads to the question of what directs them to function differentially. We 
hypothesize that the two proteins are activated by differential upstream signaling 
pathways. We investigated the role of calcium signaling in zebrafish MHB 
morphogenesis. Inhibition of cytosolic calcium by the pharmacological drug, 2-APB 
showed that calcium regulates MHBC cell length, a phenotype similar to NMIIA 
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knockdown. We further show that the shorter MHBC cell length phenotype seen 
by overactivation of NMII is rescued by inhibition of cytosolic calcium. Thus, we 
hypothesize that calcium signals differentially to NMIIA, and not NMIIB. Further 
investigation of these pathways will help answer the question of how NMII proteins 
are regulated to carry out distinct functions. Identifying these mechanisms will 
advance the understanding of the molecular basis for morphogenetic processes 
during brain formation and are likely to be applicable to developmental events 
throughout the embryo. 
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CHAPTER 1 
INTRODUCTION 
 
A. BRAIN MORPHOGENESIS 
Morphogenesis is a developmental process that gives shape to an organism and 
may occur at the level of a cell or tissue. Proper shape elicits proper function and 
this demonstrates the importance of morphogenesis in the context of structure-
function abnormalities. Developmental disorders such as neural tube defects result 
from defects in morphogenesis and while birth defects are as frequent as one in 
every thirty three babies, 70 percent of birth defect causes are still unknown 
indicating the importance of determining the molecular mechanisms leading to 
these developmental disorders (Rynn, 2009).  
During development, tissue morphogenesis plays an important role in giving rise 
to vital organs such as the brain, a highly complex and dynamic organ that controls 
the entire body. Brain morphogenesis begins early in development and involves 
the rearrangement of cells and folding of tissue sheets to give it a characteristic 
shape. Any structural abnormality in the formation of the brain, as seen in neural 
tube defects such as anencephaly and hydrocephaly can have adverse effects 
often resulting in fatal disruption of regular brain function. Brain morphogenesis 
begins with neurulation- the process of neural tube formation from the ectoderm 
(Colas and Schoenwolf, 2001) (Fig. 1A). Post neurulation, the neural tube, formed 
from a single layer of pseudo-stratified columnar epithelial cells, undergoes a 
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series of morphogenetic changes leading to tissue folding that divides the tube into 
the forebrain, midbrain and hindbrain (Lowery and Sive, 2009) (Fig. 1B). This 
process of fold formation occurs alongside the formation of the brain ventricular 
system within the neural tube. The ventricles of the brain constitute an 
interconnected system of cavities where cerebrospinal fluid is produced and 
circulated. The deepest point of constriction between the midbrain and hindbrain, 
the midbrain-hindbrain boundary constriction (MHBC), is one of the first folds 
formed during vertebrate brain morphogenesis (Gutzman et al., 2008). The 
midbrain eventually forms part of the tectum, responsible for auditory and visual 
reflexes in the adult brain; while the hindbrain forms the cerebellum, pons and 
medulla, parts of the adult brain with vital functions in motor control, cognitive 
functions, hearing and equilibrium (Louvi et al., 2003). Being a distinct and 
important first fold in the developing vertebrate brain, the midbrain-hindbrain 
boundary serves as a useful model to study brain formation and has allowed us to 
uncover novel mechanisms of tissue morphogenesis (Gutzman et al., 2015) .   
B. ZEBRAFISH MHB  DEVELOPMENT AND MORPHOGENESIS 
MODEL 
The midbrain-hindbrain boundary (MHB) is one of the earliest folds visible in the 
embryonic brain and is highly conserved across vertebrate species including 
human, mouse, chick and zebrafish (Lowery and Sive, 2009). The MHB tissue is 
the isthmic organizer, a neural signaling center that expresses transcription factors 
and signaling molecules that pattern the tissue to give it a mesencephalic 
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(midbrain) or metencephalic (hindbrain) fate (Louvi et al., 2003). Before 
morphogenesis, the neural tissue is patterned by the Fgf and Wnt genes to 
establish cell fates. Fgf8b activates the Ras-ERK pathway and induces cerebellar 
development (Sato et al., 2004). Wnt8 is involved in posteriorisation of the neural 
tube and is important for the onset of otx2 and gbx1 expression (Rhinn et al., 2005). 
Otx2 expression establishes a midbrain fate while gbx2 determines a hindbrain 
fate (Barkovich et al., 2009; Dworkin and Jane, 2013). The different stages of MHB 
tissue establishment are positioning, induction, and maintenance. The expression 
of patterning genes involved during each these steps have been relatively well 
studied (Martinez, 2001). Morphogenesis is now considered a fourth, distinct stage 
in MHB development and the molecular mechanisms that regulate MHB 
morphogenesis are the focus of more recent studies (Giraldez et al., 2005; 
Gutzman et al., 2008).  
We use zebrafish as a model system to study the mechanisms involved in the 
formation of the midbrain-hindbrain boundary. Zebrafish is favorable due to various 
advantages. Zebrafish are easy to handle, breed, and have a faster embryonic 
developmental timeline when compared to other models (Kimmel et al., 1995). 
They produce large clutches of embryos which undergo synchronous 
development, allowing for a large sample size in experiments. Ex-utero 
development and transparency of embryos make it an excellent vertebrate model 
for early developmental studies because it allows for micromanipulation and high-
resolution imaging to visualize cell shapes. Importantly, 70 percent of protein-
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coding human genes have at least one ortholog in the zebrafish, which helps to 
correlate findings between the two organisms (Howe et al., 2013). 
Zebrafish midbrain-hindbrain boundary morphogenesis occurs between 18 and 24 
hours post fertilization (hpf) (Fig. 2). At 18 hpf, or 18 somite stage (ss), the 
hindbrain ventricle first starts opening, followed by the midbrain ventricle at around 
20 hpf, or 22 ss. As these ventricles inflate due to secretion of embryonic 
cerebrospinal fluid, the neural tube gets segregated into three regions- the 
forebrain, midbrain and hindbrain. Boundaries between each of these regions 
begin appearing as a result of folding of the neuroepithelium. The junction between 
the midbrain and the hindbrain, the midbrain-hindbrain boundary is seen as a 
distinct fold in the tissue starting at 20 hpf (Gutzman et al., 2008). This progressive 
formation of the MHB to a distinct fold in the early neural tube structure can be 
observed through further time points from 22 hpf (24 ss) to 24 hpf (prim-6) (Fig. 
2A-D). The cell shape changes occurring during this time have been previously 
characterized (Gutzman et al., 2008). At 17 hpf, the neuroepithelial cells of the 
MHB are of similar length. By 21-22 hpf, cells at the MHB shorten by about 25% in 
comparison to cells on the hindbrain side of the MHB and they further undergo 
apical expansion and basal constriction such that by 24 hpf, the midbrain-hindbrain 
boundary constriction (MHBC) is completely formed and the ventricles are open 
(Gutzman et al., 2008). We were interested in the early time point of 22 hpf or 24 
ss, because this is when the tissue first folds between the midbrain and the 
hindbrain, forming the midbrain-hindbrain boundary. Understanding the 
5 
 
 
 
mechanisms that drive the formation of this initial fold will enable us to understand 
more complex morphogenetic processes that occur during development. 
C. CELL SHAPE CHANGES LEAD TO TISSUE 
MORPHOGENESIS 
During epithelial tissue morphogenesis, cells undergo changes in shape to enable 
the tissue to fold. Cellular morphogenesis can occur in various ways depending on 
the morphogenetic event required during that particular time of development. 
Some cell shape change mechanisms have been extensively studied in various 
models and will be the focus of this section.  
An epithelial tissue has a distinct apical-basal polarity and cells of that tissue can 
change shape in multiple ways (Fig. 3). Cells can elongate to become columnar 
which happens when neural plate is formed, as the first step of neurulation 
(Schoenwolf and Franks, 1984) (Fig. 3A). Epithelial cells also undergo shortening 
along the apicobasal axis as seen in initial midbrain-hindbrain boundary formation, 
leading to tissue folding (Fig. 3B) (Gutzman et al., 2008). Additionally, shortening 
may occur along the lateral sides to cause flattening of tissue as seen during 
epiboly in zebrafish and frog embryos, and in drosophila wing imaginal disc 
formation (Fig. 3C) (Barkovich et al., 2009; Fristrom, 1988; Keller, 1980). In the 
zebrafish Kupffer’s vesicle, a combination of regionalized cell shape changes 
occur where anterior cells elongate and posterior cells shorten, displaying apical 
expansion (Wang et al., 2012).  Additionally, cells can undergo changes on either 
the apical side or the basal side. Apical constriction is a common cell shape change 
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that occurs during many developmental processes (Fig. 3D) (Sawyer et al., 2010). 
It occurs during ventral furrow formation in Drosophila (Kam et al., 1991; Leptin, 
1999), gastrulation in C.elegans (Lee and Goldstein, 2003) and in vertebrates, 
involving bottle cells of the Xenopus dorsal marginal zone (Lee and Harland, 2007) 
and cells in the mouse embryo during neural tube closure (Bush et al., 1990). 
Although apical constriction has been well studied, examples of basal constriction 
in development are few (Fig. 3E). During brain morphogenesis, cells at the 
midbrain-hindbrain boundary undergo basal constriction to form the distinct 
constriction between the midbrain and hindbrain (Gutzman et al., 2008). Basal 
constriction has also been described in zebrafish during optic cup morphogenesis 
(Martinez-Morales et al., 2009). 
Individual cell shape changes lead to tissue morphogenesis and the basic cell 
shape changes discussed above are usually a precursor step to more complicated 
tissue shape changes like folding, invagination and evagination. Invagination 
occurs when the epithelial tissue folds, often as a consequence of apical 
constriction (Llimargas and Casanova, 2010), while evagination leads to 
outpocketing of cells (Schock and Perrimon, 2002).  
Cell shape changes are vital to morphogenesis and although there have been 
studies in various organisms during different stages of development, extensive 
studies of cellular morphogenesis in vertebrate systems is lacking. Here, we have 
studied the cell shape changes, and the molecular mechanisms by which those 
changes are regulated during midbrain-hindbrain boundary morphogenesis in a 
vertebrate model, the zebrafish. 
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D. FACTORS INFLUENCING CELL AND TISSUE 
MORPHOGENESIS 
Morphogenetic processes are regulated by multiple factors involving tissue 
specific gene expression and protein regulation. Genes are transcribed and mRNA 
is translated to produce functional proteins. These proteins signal downstream to 
direct mechanical changes that ultimately cause cell and tissue morphogenesis 
(Fig. 4). Mechanical forces are ones that govern the architecture of the cell and 
establish the stability of the tissue. This stability of epithelia is dependent on two 
factors- the cytoskeleton and the extracellular matrix, which determines the 
strength and structure of the cell inside and outside (Fletcher and Mullins, 2010). 
Some of these factors that are critically important for morphogenesis will be 
discussed next.  
Cytoskeleton 
The cytoskeleton is a network of intracellular proteins that comprise of 
microfilaments, microtubules and intermediate filaments. Within the cell, the 
cytoskeleton gives it a backbone of support. Most cell shape changes discussed 
in the previous section require microfilaments or microtubules to carry out shape 
changes, and these will be discussed  next (Mammoto and Ingber, 2010). 
Actomyosins  
Actin filaments are helical polymers of the protein, actin. This cytoskeletal 
component is highly enriched at the cell periphery, forming the cell cortex. Myosins 
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are specialized motor proteins that associate with actin and move along actin 
filaments to carry out force transduction (Fletcher and Mullins, 2010). They are a 
huge family of proteins, and non-muscle myosins II are a class of proteins found 
in all cells that are actively involved in cellular morphogenesis. Actomyosin 
complexes are known to play an important part in a variety of cellular functions 
involving cell motility, cell division, maintenance of tissue integrity, morphogenesis, 
and cell shape (Vicente-Manzanares et al., 2009).  Apical constriction, one of the 
well-studied cell shape changes discussed above, is attributed to actomyosin 
activity. It is responsible for pulsed contractions that drive morphogenetic 
processes during gastrulation in C. elegans, Drosophila and Xenopus (Lee and 
Goldstein, 2003; Lee and Harland, 2007; Martin et al., 2009). Apical constriction is 
just one example depicting the role of actomyosins, as they play a role in almost 
all other cell shape changes (Fristrom, 1988; Schock and Perrimon, 2002).  
Microtubules 
The cytoskeleton is also comprised of microtubules, which are polymers of the 
protein tubulin and they arise from the centrosome. Microtubules are associated 
with the motor proteins, kinesin, that move away from the centrosome and dynein, 
that move towards the centrosome (Fletcher and Mullins, 2010). Microtubules are 
primarily responsible for cell division and cargo movement across the cell but they 
are also required for cell shape maintenance in events such as gastrulation in 
Xenopus and zebrafish (Lee and Harland, 2007; Sepich et al., 2011). Disruption of 
microtubule networks leads to increase in actin networks and adhesion dependent 
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signaling which hints toward microtubule involvement in regulation of cell shape 
(Elbaum et al., 1999; Rodionov et al., 1993). 
Extracellular matrix  
The physical properties of tissues are also determined by the extracellular matrix 
(ECM), which is composed of a variety of polysaccharides and proteins that form 
a meshwork outside the cell. The proteins produced here can be fibrous such as 
collagen and elastin, or adhesive, such as fibronectin and laminin. In epithelial 
cells, the boundary between the epithelium and the underlying connective tissue 
is called the basal lamina and laminin allows attachment of the tissue to the basal 
lamina (Parsons et al., 2010). Epithelial tissues have an apical-basal polarity with 
the lamina being on the basal side. During neural tube morphogenesis, constriction 
along the basal side allows formation of the zebrafish midbrain-hindbrain 
boundary, and this process has been shown to be laminin dependent (Gutzman et 
al., 2008).   
Cell adhesion  
Cell adhesion is the binding of cells within a tissue, to each other or to the 
extracellular matrix and is an important factor in morphogenesis, especially when 
cell movement is involved. The basal lamina is connected to the cell through cell-
matrix adhesion molecules, integrins. Integrins are transmembrane receptors that 
are connected to the ECM through laminin and internally, to cytoskeletal actin 
stress filaments which allow the transmission of physical forces through the tissue, 
enabling morphogenesis (Barone and Heisenberg, 2012). Focal adhesion 
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molecules serve as a mechanical link to transduce force between the cell and the 
matrix. Integrin mediated focal adhesion kinase (FAK) signaling connects the basal 
lamina to intracellular actomyosins (Westhoff et al., 2004). FAK is localized at focal 
adhesions, interacts with paxillin, and is required for microtubule and spindle 
reorientation, making it essential for epithelial morphogenesis, determined by 
studies in Xenopus embryos and human cell lines. (Petridou and Skourides, 2014). 
Adherens junctions anchor the cytoskeleton, specifically actin filaments of a cell to 
that of another cell or the ECM. Neighboring cells within the epithelial tissue are 
connected through cell-cell adhesion molecules, cadherins. Cadherins are calcium 
dependent cell adhesion molecules and they play an important role in brain and 
nervous system development (Redies and Takeichi, 1996). Various cadherin 
isoforms are required during different stages of nervous system development such 
as neural tube and neuroepithelial layer formation, boundary formation and in the 
formation of brain nuclei and ganglia (Hirano and Takeichi, 2012).    
Cell migration 
Cell migration, or movement of cells, is critical to development as it allows cells to 
reach their destined location where they can differentiate and lead to development 
of organs (Aman and Piotrowski, 2010). Some of the most widely studied migratory 
events are gastrulation and neural crest cell migration. Cell migration in individual 
cells occurs through extension of actin filled lamellipodia, indicating the importance 
of the cytoskeleton in cellular morphogenesis (Giannone et al., 2007; Ponti et al., 
2004). A decrease in cell adhesion causes an increase in cell motility, showing the 
interdependence of some of the factors discussed (Du et al., 2012).  
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Cell intercalation  
Cell intercalation is the interspersing of individual cells between other cells and is 
also an important factor in some cellular morphogenetic events. The classic 
example of cell intercalation occurs during the process of convergence and 
extension. During this process mediolateral cells intercalate between cells along 
the anteroposterior axis of the embryo resulting in its narrowing and elongation 
along the anteroposterior body axis (Sepich et al., 2005). Cells also undergo 
rearrangement in the form of radial intercalation as seen during epiboly in Xenopus 
embryos where the inner layer of cells move out to the superficial layer and 
undergo convergence and extension. This process is also critically dependent 
upon cell-cell adhesion, again showing interconnection between factors (Marsden 
and DeSimone, 2001).  
Cell division 
Morphogenetic changes can occur due to the active growth of tissue which is 
regulated by region specific increases in cell proliferation, making cell proliferation 
another essential regulator of morphogenesis. In kidney development, the 
elongation of renal tubes requires extensive cell division (Jung et al., 2005). Wound 
healing is another example where cell division is required for replacement of lost 
or damaged tissue. In the drosophila wing imaginal disc, cells respond to tissue 
damage by changing their cell division orientation (Ruiz and Serras, 2014). In 
contrast to increased cell division, at times, cell division is stalled for the 
morphogenetic event to proceed, as seen in drosophila gastrulation to enable cell 
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shape changes (Seher and Leptin, 2000). In the zebrafish brain, greater cell 
proliferation is observed in the midbrain and hindbrain ventricle regions of the 
neural tube, indicating the role of cell proliferation in ventricle inflation (Lowery and 
Sive, 2005).   
Cell death 
Cell death is an integral process in development and has been described 
classically in C. elegans to occur by a tightly controlled genetic pathway involving 
genes ced-3, ced-4 and ced-9 that induce programmed cell death, apoptosis (Ellis 
et al., 1991). Cells in the interdigital spaces during animal limb formation undergo 
extensive apoptosis (Merino et al., 1999) and significant amounts of cell death 
occurs during Drosophila head involution and moth metamorphosis (Ellis et al., 
1991; Grether et al., 1995).  
Thus, morphogenesis can be controlled through a variety of complex processes. 
Elucidating the molecular mechanisms that regulate cell shape changes during 
brain morphogenesis has been challenging due to the complexities of the 
vertebrate system, the number of potential signaling pathways, and the likely 
interactions between factors and pathways. We are using the developing zebrafish 
midbrain-hindbrain boundary to understand the factors that regulate cell shape 
changes during morphogenesis.   
E. NON-MUSCLE MYOSIN II  
Non-muscle myosin II proteins are cytoskeletal molecular motors present in all 
cell types and, in association with actin filaments, carry out vital functions of cell 
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division, cell migration and cell shape maintenance (Sellers, 2000). Using the 
zebrafish midbrain-hindbrain boundary as a model, we studied the role of non-
muscle myosin II (NMII) in regulating cell shape changes occurring during this 
process.   
Classification and structure 
The myosins are a superfamily of 35 classes of ATP-driven motor proteins that 
work in coordination with actin filaments (Odronitz and Kollmar, 2007). The class 
II myosin family includes NMII proteins which are present in all eukaryotic cells and 
are known to be involved in cell migration, cell adhesion, cytokinesis and cell shape 
(Sellers, 2000). Structurally, all class II myosins have a pair of heavy chains and 
two pairs of light chains- essential and regulatory light chains (Golomb et al., 2004) 
(Fig. 5). The heavy chains have a globular head domain and a long tail domain 
that forms a coiled rod-like helical tail and a terminal non-helical end. The two pairs 
of light chains are attached non-covalently to the heavy chain at the neck domain 
(Fig. 5). The head domain contains the ATP and actin binding units which allow for 
a change in conformation of the head domain enabling the molecule to convert 
ATP energy to mechanical energy and move along actin filaments (Pollard and 
Korn, 1973). The essential light chain is required for filament assembly and 
stability, while the regulatory light chain, apart from filament stability, plays a critical 
role in regulation of the active state of the molecule (Vicente-Manzanares et al., 
2009). Overall, myosin II can exist in a compact folded conformation due to its C-
terminal tail domain being linked to the neck region by a ‘proline-kink’ or in an 
elongated, filamentous form, where multiple myosin II molecules assemble in a 
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parallel or anti-parallel fashion to form thick filaments (Onishi and Wakabayashi, 
1982; Trybus et al., 1982). In the filament form, actomyosin complexes can 
transduce force within the cell and between cells in a tissue (Onishi and 
Wakabayashi, 1982; Trybus et al., 1982).  
Isoforms and functional differences 
In mammals, there are three NMII isoforms, NMIIA, NMIIB and NMIIC, which differ 
from each other by the structure of their heavy chains. These are encoded by the 
genes myh9, myh10 and myh14, respectively (Fig. 6) (Golomb et al., 2004). 
Zebrafish also have three isoforms with the exception that there are two ohnologs 
for the human MYH9 gene- myh9 and myh9a (Flicek et al., 2014). Although the 
three isoforms have a high degree of heavy chain sequence similarity with 
differences mainly in the terminal tail portion, they have different binding affinities 
to actin, which results in a difference in their kinetic properties (Heissler and 
Manstein, 2011; Kovacs et al., 2003; Wang et al., 2011).  
All three gene isoforms have a vast, yet distinct tissue expression. This suggests 
that in spite of the high degree of sequence similarities between them, their 
activation state and kinetic properties enable them to have potentially distinct 
functions. NMIIA is predominantly expressed in platelets and spleen, NMIIB is 
expressed largely in neuronal tissues (Calaminus et al., 2007). Most human fetal 
tissues express significantly less amounts of NMIIC, in comparison to NMIIA and 
NMIIB (Golomb et al., 2004). NMIIC also has low expression in adult mouse 
tissues, with significant amounts detected only in lung tissue and in cell cultures 
(Ma et al., 2010).  
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Distinct functions for each of the isoforms have been identified which suggests that 
each may be differentially regulated. NMIIA is important for cell migration and 
knockout mice fail to develop a visceral endoderm layer (Sandquist et al., 2006). 
NMIIB functions in cell motility and tissue organization and these knockout mice 
display severe cardiovascular and brain defects including hydrocephaly (Getty et 
al., 2011; Tullio et al., 1997; Tullio et al., 2001). Being a recently identified homolog, 
compared to NMIIA and NMIIB, not much is known about the functional role and 
kinetics of NMIIC (Golomb et al., 2004; Heissler and Manstein, 2013). It has a 
lower homology of 62% between human and fish, compared to around 75% for 
NMIIA and 90% for NMIIB, and is more closely related to muscle myosin than to 
other NMII proteins (Flicek et al., 2014). Further, the NMIIC knockout mice survive 
to adulthood with no obvious phenotypes, while their IIA and IIB counterparts do 
not (Ma et al., 2010). As also mentioned earlier, NMIIC has low expression in fetal 
tissues (Golomb et al., 2004). Due to these reasons, we have focused our current 
study on the role of NMIIA and NMIIB in regulating brain morphogenesis. 
Regulation of non-muscle myosin II activity 
 Activation by light chain phosphorylation 
In the zebrafish, there are multiple isoforms of the myosin regulatory light chain; 
however, only one isoform has been identified to be specific for non-muscle myosin 
II (myl12.1) (Flicek et al., 2014). Activation of NMII molecules is primarily carried 
out by the phosphorylation of the regulatory light chain at two sites- serine-19 and 
threonine-18 (Somlyo and Somlyo, 2003). Phosphorylation at either ser-19 alone, 
or both ser-19 and thr-18 increases the Mg2+-ATPase activity of myosin and its 
16 
 
 
 
association with actin, causing activation of the entire molecule (Somlyo and 
Somlyo, 2003; Vicente-Manzanares et al., 2009). The myosin specific enzyme, 
myosin light chain kinase (MLCK), phosphorylates and activates the regulatory 
myosin light chain (MLC) (Nishikawa et al., 1984). There are three MLCK isoforms- 
a long non-muscle isoform, a short smooth muscle isoform, and a telokin with no 
enzymatic activity (Guo et al., 2013). The non-muscle MLCK has been shown to 
be involved in cell migration (Reynoso et al., 2007) and cell adhesion (Xu et al., 
2008). It is also known to be regulated in a calcium-calmodulin dependent manner 
in smooth muscle (Martinsen et al., 2013; Mizuno et al., 2008). A variety of other 
enzymes also phosphorylate the MLC and they include Rho, Rho associated 
coiled-coil kinase (ROCK), myotonic dystrophy kinase-related cdc42-binding 
kinase (MRCK), protein kinase A (PKA) and mitogen activated protein kinase 
(MAPK), among others (Fig. 7) (Betapudi, 2014; Matsumura, 2005; Vicente-
Manzanares et al., 2009). Myosin phosphatase dephosphorylates the MLC, 
inactivating NMII. Rho also inhibits mypt1, a subunit of the myosin phosphatase, 
and in this way it can indirectly activate NMII (Chu et al., 2012). 
Activation by heavy chain phosphorylation 
NMII proteins can also be regulated by multiple serine and threonine 
phosphorylation sites on the tail domain of the heavy chain, some of which are 
specific to individual homologs. The NMIIA heavy chain has a thr-1800, ser-1803 
and ser-1808 site in the coiled-coil portion of the tail and a ser-1943 site in the non-
helical tail domain, which is phosphorylated by casein kinase II (Clark et al., 2008). 
Absence of this phosphorylation prevents the binding of NMIIA to s100A4, member 
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of the s100 family of calcium binding proteins. This results in inhibition of filament 
assembly, disrupting its regular function (Dulyaninova and Bresnick, 2013).The 
NMIIB heavy chain also has a ser-1937 site phosphorylated by protein kinase C 
(PKC), which is responsible for filament assembly (Vicente-Manzanares et al., 
2009). These distinct sites in the two homologs phosphorylated by different 
enzymes, but carrying out the same function could indicate a differential regulation 
of the NMII proteins at the level of the two heavy chains (Dulyaninova and 
Bresnick, 2013).  
Inactivation of non-muscle myosin II  
Phosphorylation on other sites of the MLC, including ser-1, ser-2 and thr-9 and 
dephosphorylation on ser-19 or thr-18 are known to deactivate NMII (Betapudi, 
2014; Vicente-Manzanares et al., 2009). A myosin specific enzyme that directly 
dephosphorylates the MLC is the myosin phosphatase, which results in 
inactivation of the myosin molecule (Ito et al., 2004). Myosin phosphatase has 
three subunits- PP1c, MYPT1 and M20. PP1c and M20 interact with the N and C 
terminal domains of MYPT1 and affect its function. The PP1 subunit of myosin 
phosphatase dephosphorylates the MLC, inactivating the entire myosin molecule 
(Fig 7). Mypt1 zebrafish mutants show an abnormal neuroepithelial cell shape 
phenotype in the hindbrain, indicating the importance of NMII in brain development 
(Gutzman and Sive, 2010). Mypt1 has also been implicated in key developmental 
processes involving convergence extension, gastrulation, and dorsal closure 
which involve NMII functions (Conti and Adelstein, 2008; Franke et al., 2005; 
Heissler and Manstein, 2013).   
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Upstream signaling pathways regulating NMII phosphorylation state 
Based on the vast literature of the structure and function of NMII isoforms, it is 
surprising that it is still not well understood if they function differentially and how 
they are differentially activated. Many studies in the last few decades have tried to 
tease out the mechanism in which NMII is regulated to carry out its function. The 
multiple kinases and phosphatases discussed in the previous section only depict 
the regulation of NMII at one level. Upstream of each of these enzymes are multiple 
signaling molecules that carry out molecular cross-talk within the cell and 
extracellularly. NMII is activated by ROCK mediated phosphorylation of the MLC 
(Nakajima and Tanoue, 2010). Shroom3 is a recently identified protein required for 
apical constriction in chick and mouse neural tube closure (Nishimura and 
Takeichi, 2008). It recruits ROCK to apical cell junctions. Shroom3 mutants and 
morphants show reduced accumulation of F-actin and phosphorylated MLC, 
indicating its role in regulating NMII (Hildebrand and Soriano, 1999; Nishimura and 
Takeichi, 2008). In the same context, the Rho-ROCK signaling axis has been 
widely studied for its role in morphogenetic processes that especially involve 
cytoskeletal remodeling and cell shape changes (Suzuki et al., 2012).  Inhibition of 
Rho causes a decrease in phosphorylation of the MLC and leads to defects in 
neural tube closure (Kinoshita et al., 2008). Further, the Rho-ROCK axis is known 
to be regulated by Wnt and the planar cell polarity (PCP) pathway in vertebrate 
cardiac development (Phillips et al., 2005). Calcium mediated regulation of myosin 
II has been studied intensely in muscle contraction, and more recently, in non-
muscle cells as well (Szent-Gyorgyi, 1975). Calcium regulates myosin II 
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phosphorylation through MLCK in smooth muscle and endothelium (Martinsen et 
al., 2013). The JNK pathway also controls NMII localization in fly wound healing 
(Kwon et al., 2010). Thus, there are multiple signaling pathways regulating NMII 
and we are interested in understanding this regulation during zebrafish midbrain-
hindbrain boundary morphogenesis. We are specifically interested in the role of 
calcium signaling, which will be covered in the next section.   
F. CALCIUM SIGNALING PATHWAY  
Calcium signaling in development and regulation of cell shape 
Calcium has been implicated in early development during various events 
(Slusarski and Pelegri, 2007). Waves of calcium are observed in dorsal explants 
of Xenopus embryos and inhibition of calcium causes convergence and extension 
defects (Wallingford et al., 2001). In zebrafish embryos, intercellular calcium waves 
are observed at the margin of gastrulating embryos (Gilland et al., 1999). Calcium 
signaling is also important in maintenance of left-right body axis during 
development. In zebrafish, cilia in the Kupffer’s vesicle collectively beat in a 
coordinated left-sided rotation to produce a calcium gradient that regulates left-
right symmetry of visceral organs (McGrath et al., 2003; Sarmah et al., 2005). 
Similarly, in chick embryos, left-right axis determination requires extracellular 
calcium waves (Raya et al., 2004). Calcium channel blockade causes defects in 
organ formation, as seen in heart morphogenesis (Porter et al., 2003). Thus, 
calcium is required in many vital developmental processes and could potentially 
be important in midbrain-hindbrain boundary morphogenesis.  
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Calcium also plays a role in cell shape changes. Regulation of platelet shape has 
been widely studied and is regulated by calcium induced phosphorylation of the 
MLC (Porter et al., 2003). Calcium entry into the cell through store operated 
calcium channels (SOC) causes cell shape changes in pulmonary endothelial cells 
by rearrangement of microfilaments (Moore et al., 1998). During wound healing in 
the Xenopus ectoderm, cell shape changes at the edge of the wound are disrupted 
when calcium levels are pharmacologically altered (Stanisstreet, 1982). Thus, we 
hypothesize that calcium may have a critical role in regulation of cell shape 
changes that mediate brain morphogenesis. 
Overview of the calcium signaling pathway  
Calcium signaling pathways are highly versatile and signal to affect various 
processes within the cell. Since calcium is not metabolized by the cell, it is stored 
inside cells and released when required (Berridge, 1997). A delicate balance of 
cytosolic calcium ion concentration is maintained by various channels on the 
plasma membrane or membranes of the storage organelles (Duchen, 2000). The 
basic mechanism of this pathway is calcium induced calcium release, where an 
initial amount of calcium induces the release of greater amounts of calcium from 
its intracellular stores, triggering regenerative calcium waves (Berridge et al., 
2000). Apart from calcium entry into cells from the external environment through 
channels in the plasma membrane, calcium within the cell can be released from 
membrane bound organelles that store calcium which include the endoplasmic 
reticulum (ER) and mitochondria (Fig. 8) (Duchen, 2000). A major source of stored 
intracellular calcium in non-neural cells is the endoplasmic reticulum, the release 
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of Ca2+ ions depends on the opening of specific membrane channels- the 
ryanodine (Ryr) receptor channels, SERCA channels or the inositol triphosphate 
receptor (IP3R) channels (Putney, 1986). The Ryr receptor channels are 
predominantly present in cardiac and skeletal muscles and are regulated by 
cytosolic calcium through calcium-induced calcium release (Fill and Copello, 
2002). The SERCA channels or the sarco/endoplasmic reticulum Ca2+-ATPase 
channels are exclusive to muscle cells and transport calcium ions from the cytosol 
into the sarcoplasmic reticulum (Gomez-Viquez et al., 2003). The opening of the 
IP3R channels is stimulated by inositol 1,4,5- triphosphate (IP3) which is a product 
of a signaling pathway initiated at the cell membrane through extracellular ligands. 
Hormones or growth factors can bind to extracellular receptors such as the 
receptor tyrosine kinases (RTK) or G protein coupled receptors (GPCR), activating 
phospholipase C (PLC), that converts membrane bound phosphatidylinositol 4, 5 
bisphosphate (PIP2) to IP3 and diacylglycerol (DAG) (Slusarski and Pelegri, 2007). 
The release of IP3 then allows release of calcium from the ER by stimulation of the 
IP3R (Fig. 8). Once released, calcium can act as a secondary messenger and 
signal to downstream molecules like troponin C, calmodulin and cyclic AMP 
(cAMP) which are calcium dependent proteins that can, in turn signal to various 
downstream effectors (Slusarski and Pelegri, 2007).  
Unlike other signaling molecules, which are synthesized in the body and are 
ultimately products of cellular transcription and translation, calcium, in order to be 
able to transmit signals across the cellular system, needs to bind to certain proteins 
or kinases that can transmit and induce downstream effects (Yanez et al., 2012). 
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Several calcium binding molecules exist such as calmodulin and calcineurin 
(Kawasaki et al., 1998). Calcineurin, or protein phosphatase IIB, is activated by 
calcium-calmodulin and is a serine/threonine protein phosphatase that links 
calcium to phosphorylation states of proteins. Calmodulin is one of the extensively 
studied calcium-binding proteins. It is directly affected by the concentration of 
intracellular calcium. Interestingly, MLCK is affected by calmodulin levels, 
indicating that actomyosins could be potential downstream effectors of calcium 
(Van Lierop et al., 2002). 
Calcium signaling and regulation of non-muscle myosin II 
The role of calcium in regulating myosin has been classically studied in skeletal 
muscles with respect to its function in muscle contraction (Szent-Gyorgyi, 1975). 
In comparison, the regulation of actomyosins by calcium signaling in non-muscle 
models is less studied (Somlyo and Somlyo, 2003). Calcium has been shown to 
regulate NMII through MLCK in smooth muscle and endothelium (Martinsen et al., 
2013; Watanabe et al., 2001). However, its regulation of NMII in development and 
morphogenetic processes are yet to be determined.      
We know that actin filaments in association with their molecular motors, myosins, 
drive cell shape changes during developmental processes such as germ band 
elongation, mesoderm invagination, dorsal closure and egg chamber elongation 
(He et al., 2010; Martin et al., 2009; Rauzi et al., 2010; Solon et al., 2009). 
Interestingly, most of these processes are also regulated by calcium signaling. For 
example, in the zebrafish embryo, at 75% epiboly, an actomyosin ring is formed 
along the margin and an increased amount of calcium is observed at the margin 
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during the epiboly stages (Popgeorgiev et al., 2011). We also know that NMII 
phosphorylation is carried out by MLCK, and it has been shown that the activation 
of MLCK is required for epiboly to progress (Popgeorgiev et al., 2011). Additionally, 
in the zebrafish embryo, misexpression of cAMP response element binding protein 
(CREB) causes defects in MHB morphogenesis (Dworkin et al., 2007). cAMP, 
being a common second messenger in the calcium signaling pathway, suggests 
possible calcium regulation of NMII in MHB formation (Dworkin et al., 2007; 
Dworkin and Jane, 2013).  
In the current research, we have studied the role of NMII and its regulation by 
calcium signaling during MHB morphogenesis in zebrafish. We discover that 
NMIIA regulates cell length while NMIIB regulates cell width during MHB formation 
in zebrafish. We further find that calcium is required in this process, and that it 
specifically regulates MHBC cell length. These and future findings will be important 
in expanding our knowledge of the mechanisms of other similar developmental 
processes as well.     
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Figure 1. Schematic showing early brain development and morphogenesis. 
(A) Brain is derived from the ectoderm which folds to form the neural tube by the 
process of neurulation. (B) The neural tube undergoes morphogenesis to form the 
future forebrain, midbrain and hindbrain. The midbrain-hindbrain boundary 
constriction (MHBC) is a distinct visible fold (red arrowheads). The neural tube 
develops and differentiates to eventually form the complex adult brain. F, 
Forebrain; M, Midbrain; and H, Hindbrain.   
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Figure 2. Midbrain-hindbrain boundary formation in zebrafish. (A-D) 
Brightfield dorsal images of zebrafish embryos showing midbrain-hindbrain 
boundary formation at (A) 18 hpf or 18 ss, (B) 20 hpf or 22 ss, (C) 22 hpf or 24 ss 
and (D) 24 hpf or prim-6. (A’-D’) Enlarged images of boxed regions in A-D. 
Embryos are oriented anterior to the left and posterior to the right. Hpf, hours post 
fertilization; ss: somite stage; M, midbrain; H, hindbrain. 
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Figure 3. Schematic showing various cell shape changes that can occur in 
an epithelial tissue during morphogenesis. (A) cell elongation, (B) cell 
shortening, (C) flattening, (D) apical constriction, and (E) basal constriction.  
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Figure 4. Schematic showing various cellular factors that can affect 
morphogenesis. 1. Specific gene expression is initiated in the nucleus and mRNA 
is transcribed and then translated to produce functional proteins. 2. Intracellular 
proteins and extracellular ligands signal to intermediate molecules. 3. Mechanical 
forces generated by cytoskeletal elements- (3a) microfilaments and (3b) 
microtubules ultimately carry out specific cell shape changes resulting in 
morphogenesis. 
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Figure 5. Non-muscle myosin II structure. Diagram of the basic structure of 
non-muscle myosin II proteins showing the heavy and light chains along with the 
head, neck and tail domains.  
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 Figure 6. Non-muscle myosin II genes. Schematic showing the different non-
muscle myosin II (NMII) homologs- NMIIA, NMIIB and NMIIC, encoded by their 
respective genes- MYH9, MYH10 and MYH14. Corresponding analogous genes 
in the zebrafish are also shown. 
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Figure 7. Regulation of the phosphorylation state of non-muscle myosin II. 
Schematic showing activation of non-muscle myosin II by phosphorylation of the 
regulatory light chain by myosin light chain kinase and dephosphorylation by 
myosin phosphatase. Shown in grey are various other kinases that also regulate 
the phosphorylation state of non-muscle myosin II molecules. DAPK, Death 
Associated  Protein Kinase; ZIPK, Leucine Zipper interacting kinase; MRCK, 
Myotonic Dystrophy kinase related CDC42-binding Kinase; ROCK, Rho-
associated coiled-coiled kinase; PKC, Protein Kinase C; P, phosphate molecule.  
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Figure 8. Schematic representing the proposed hypothesis. Diagram 
representing the hypothesis that calcium signals to regulate non-muscle myosin II 
by phosphorylation of the myosin light chain. A major source of intracellular 
calcium is the endoplasmic reticulum (ER). Calcium is released by the opening of 
the IP3R channels on the ER membrane. Red arrow indicates hypothesized 
interaction.  
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CHAPTER 2 
NON-MUSCLE MYOSIN IIA AND IIB DIFFERENTIALLY 
REGULATE CELL SHAPE CHANGES DURING 
ZEBRAFISH BRAIN MORPHOGENESIS 
*THIS CHAPTER HAS BEEN ADAPTED FROM: 
 
Jennifer H. Gutzman, Srishti U. Sahu, Constance Kwas 
Developmental Biology, Volume 397, Issue 1, 1 January 2015, Pages 103–115 
 
Contributions: Work performed by Srishti Sahu includes partial contribution to 
Figures 9-13, S1, S3 and sole contribution to Figure S4.      
 
A. INTRODUCTION 
Morphogenesis is a key developmental process that shapes all organs and is 
required for proper organ function. Regulation of individual cell shape changes are 
at the core of morphogenetic events which together give rise to whole tissue shape 
(Heisenberg and Bellaiche, 2013; Lecuit and Lenne, 2007). During vertebrate brain 
development, neuroepithelial cells of the neural tube fold in specific regions giving 
rise to the characteristic embryonic vertebrate brain shape. The fold at the 
midbrain-hindbrain boundary (MHB) functions as a crucial organizing center for the 
developing embryo and is one of the earliest and most highly conserved folds in 
the vertebrate brain (Brand et al., 1996; Rhinn and Brand, 2001). Given the high 
degree of conservation of the MHB across vertebrate species in terms of function 
and form, understanding the molecular mechanisms underlying its development is 
critical to our understanding of brain morphogenesis.  
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Our previous work characterized the basic morphogenetic events that occur to 
form this highly conserved fold in the zebrafish. We demonstrated that cell 
shortening and basal constriction occur in cells at the point of deepest constriction 
of the MHB, the midbrain-hindbrain boundary constriction (MHBC) (Gutzman et al., 
2008).  While we previously determined that basal constriction is dependent on 
laminin, the mechanisms that regulate cell shortening at the MHBC are unknown.   
Neuroepithelial cell shape and brain morphogenesis are also dependent upon the 
contractile state of the neuroepithelium (Gutzman and Sive, 2010).  This contractile 
state is tightly regulated by non-muscle myosin II (NMII) activity. We demonstrated 
that mypt1, the myosin phosphatase regulatory subunit, is required for cell shape 
regulation during hindbrain morphogenesis and important for regulating the activity 
of NMII (Gutzman and Sive, 2010). Myosin phosphatase dephosphorylates the 
myosin regulatory light chain (MRLC) where MRLC, in the phosphorylated state, 
activates the contraction of NMII. NMII proteins are critical regulators of cell 
motility, cytokinesis, polarity, and adhesion. In addition, it has been established in 
multiple systems, that cell shape is critically dependent upon NMII function 
(Vicente-Manzanares et al., 2009).  
Depending on the tissue and cell type, NMIIA and NMIIB may have either 
overlapping or distinct roles during embryonic development (Wang et al., 2011). 
For example, NMIIA and NMIIB knockout mice have different phenotypes. NMIIA 
knockouts are embryonic lethal and die before gastrulation due to defects in cell-
cell adhesion (Conti et al., 2004). In contrast, NMIIB knockout mice display heart 
defects, hydrocephalus, and abnormal neuronal migration (Ma et al., 2007; Ma et 
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al., 2004).  In migrating cells, NMIIA and NMIIB have different localization and 
function, which depends on the rigidity of the specific migratory substrate (Raab et 
al., 2012).  
Given that non-muscle myosins have important roles in regulating cell and tissue 
shape, we hypothesized that NMIIA and NMIIB regulate cell shape changes that 
occur to form the MHBC. Here we used the zebrafish MHB as a model for 
determining the molecular mechanisms regulating the initial cell shape changes 
that occur during brain morphogenesis. We discovered distinct roles for NMIIA and 
NMIIB in MHB morphogenesis using live imaging to quantify changes in cell shape. 
We determined that NMIIA controls the length of the cells specifically at the MHBC, 
while NMIIB regulates the width of cells throughout the MHB tissue. Thus NMIIA 
and NMIIB perform non-redundant functions in regulating the morphogenesis of 
the MHB.  
B. MATERIALS AND METHODS 
Zebrafish maintenance and husbandry 
Standard procedures were used for zebrafish maintenance and husbandry 
(Kimmel et al., 1995; Westerfield, 2000). Wild-type AB zebrafish embryos were 
used for all experiments. Embryos were staged according to Kimmel et al., 1995. 
For all experiments somite number was counted to allow for consistent staging 
comparisons and to eliminate the possibility of phenotypes resulting from 
developmental delay. The following equivalent staging points were used; 18 somite 
stage (ss) is equal to 18 hours post fertilization (hpf); 22 ss is equal to 20 hpf; and 
24 ss is equal to 22 hpf.  
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Embryonic gene expression analysis 
For all of our studies we used the following sequence information from Zebrafish 
Ensembl (Flicek et al., 2013). myh9a located on the reverse strand of 
chromosome 6, ENSDART00000149823. myh9b located on the reverse strand of 
chromosome 3, ENSDART00000137105.  myh10 homolog was found to be 
located on the forward strand of a different region of chromosome 6, 
ENSDART00000151114. RT-PCR was conducted on RNA isolated from wild-
type embryos over time. Primers used include:   
myh9a forward primer (5’-AAATTCAGCAAGGTGGAGGA-3’);  
myh9a reverse primer (5’-TTGGTGTTTTCGGTTTTTCC-3’);  
myh9b forward primer: (5’-CCTGCCCATCTACTCAGAGG-3’);  
myh9b reverse primer (5’-TGTGGAAGGTTCGCTCTTCT-3’);  
myh10 forward primer (5’-CTTCTGAACGGCATGGATTT-3’);  
myh10 reverse primer (5’-TTGGCATTTCCAAAGGATTC-3’);  
Ef1α forward primer (5’-GATGCACCACGAGTCTCTGA-3’);  
Ef1α reverse primer (5’-TGATGACCTGAGCGTTGAAG-3’). 
Antisense morpholino oligonucleotide injections 
Splice site-blocking morpholino antisense oligonucleotides (morpholino: MO) were 
used for all knockdown experiments. MO details for each gene are as follows: 
myh9a MO (5’-AGCAAGAGAGACTTACAAATCGAGA-3’; Gene Tools) that 
targets intron1-EXON2. myh9b MO (5’-ATGTCTGAAACAGTCGTTTACAA GC-3’; 
Gene Tools) that targets EXON6-intron6. myh10 MO (5’-CTTCACAAAT 
GTGGTCTTACCTTGA-3’; Gene Tools) that targets EXON2-intron2. mypt1 MO 
(5′-ATTTTTTGTGACTTACTCAGCGATG-3′; Gene Tools) that targets exon 2-
intron 2 (Gutzman and Sive, 2010). Standard control MO (5′-
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CCTCTTACCTCAGTTACAATTTATA-3′) was used were indicated (Gene Tools). 
Zebrafish p53 MO (5’-GCGCCATTGCTTTTGCAAGAATTG-3’; Gene Tools) was 
only used in conjunction with the myh9b MO (Robu et al., 2007). For all MO 
knockdown experiments, the following concentrations were used and injected into 
one cell stage embryos either alone or in conjunction with membrane targeting 
GFP (mGFP). 4ng myh9a MO, 3 ng myh9b MO with 3ng p53 MO, 3ng myh10 MO, 
5ng mypt1 MO. The concentration of control MO was equal to the highest 
concentration of any experimental MO used in that experiment. Up to 6ng of myh9a 
MO was used with no obvious brain phenotype. All confocal evaluation for myh9a 
MO was conducted at 4ng. 
In situ hybridization  
In situ hybridization was conducted according to standard procedures. RNA probes 
were designed to unique UTR sequences due to the high sequence similarities in 
the coding regions of these genes (probe regions are shown in Fig. 9). The myh9a 
probe was cloned from the 3’end into the 3’ UTR of myh9a from 24 hpf wild type 
embryos using the following primers. myh9a primer 3’end forward (5’-
TGGAGGAGACTGAGGAGGAA-3’), myh9a primer 3’UTR reverse  (5’-
GAACAGGCCGAATGAAACAT-3’) resulting in a 502 bp probe. The myh9b in situ 
probe was cloned from the 5’UTR into the 5’end of myh9b from 24 hpf wild type 
embryos using the following primers. myh9b primer 5’UTR forward (5’-
GTGGAAGAGGGAGGGAAGAG-3’), myh9b primer 5’end reverse (5’-
AAGGCACCCACACTAGCTTC-3’) resulting in a 290 bp probe. The PCR 
fragments above were subcloned into pGEM using the pGEM T-Easy Vector 
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System Kit (Promega) for probe synthesis. The myh10 in situ probe was made 
from Image clone 8801976 from Open Biosystems and is located in the 3’UTR of 
the gene and results in an 810 bp probe. Sense and antisense probes were made 
and used for each in situ experiment to test for specificity. 
Actin staining 
Embryos were fixed in 4% paraformaldehyde for 2 h at room temperature or 
overnight at 4 °C and washed in PBT. Embryos were incubated at 4 °C overnight 
in Alexa Fluor 488 phalloidin (Invitrogen A12379) 1:40 in PBT, washed 3X in PBT, 
mounted in glycerol, and imaged using a Nikon CS2 laser-scanning confocal 
microscope. Images were analyzed with Nikon Elements software and Photoshop 
(Adobe). 
Non-muscle myosin IIA and IIB immunostaining 
Embryos were fixed in Dents for 2 h at room temperature, deyolked, blocked 
overnight at 4 °C, and then washed in PBT.  Embryos were incubated in primary 
antibody (anti-myosin IIA antibody raised in rabbit, Sigma-Aldrich , M8064, 1:500; 
and anti-myosin IIB antibody raised in mouse, Santa Cruz Biotechnology, sc-
376942, 1:100) overnight at 4 °C, washed in PBT, then incubated in secondary 
antibody (Alexa Fluor 488 goat anti-rabbit, Life Technologies, 1:500 and/or Alexa 
Fluor 555 goat anti-mouse, Life Technologies, 1:500). Embryos were flat mounted 
in glycerol, imaged using a Nikon CS2 laser-scanning confocal microscope, and 
images were analyzed with Nikon elements and Photoshop (Adobe) software. 
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Imaging 
All live confocal imaging was conducted as previously described (Graeden and 
Sive, 2009) using a Nikon CS2 scanning confocal and Nikon Elements software. 
Briefly, embryos were co-injected at the one-cell stage with membrane GFP 
(mGFP) mRNA (GFP-CAXX) and the morpholinos indicated. Live embryos were 
then mounted in agarose wells on a slide and oriented for imaging. A z-series of 
images was taken for each embryo. Live confocal images presented in each figure 
are single slices taken from a z-series of images approximately 15-20 microns into 
the tissue from the dorsal surface. Brightfield and in situ hybridization imaging was 
conducted using an Olympus SZX12 stereomicroscope with an Olympus DP72 
camera. All images were processed using Nikon Elements software or Photoshop 
(Adobe).  
Cell Shape Analysis 
For all cell measurements, single cells were selected based on the ability to see 
one single cell spanning the entire width of the neuroepithelium from apical to basal 
in a single z-plane in the region of interest. Cell length was determined using the 
Nikon Imaging Systems (NIS) Elements software measurement tool by measuring 
from apical to basal of a single cell spanning the neuroepithelium. The cell width 
measurement was obtained from the NIS-Elements software as an average width 
of a cell. Single cells were manually outlined in a single z-series image to create 
an object. Then the NIS-Elements software determined the average width of the 
object (cell) by first calculating the area and the perimeter of the object (cell). The 
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software then calculated the length of the object using the formula: Length 
= (Perimeter + Sqrt (Perimeter2 – 16*Area))/4. The width of the object was in 
turn calculated using the formula: Width = Area/Length.  
Statistical Analysis 
Statistical analysis for comparisons between all treatment groups was carried out 
by ANOVA. For significant results by ANOVA, further t-tests were performed to 
determine significance between control treatment and experimental treatment 
groups. p-values for t-test comparisons are presented in each figure legend. All 
analysis was computed using R-3.0.1. 
C. RESULTS 
Expression of non-muscle myosin IIA and IIB during embryonic development 
Non-muscle myosins are known to be key regulators of cell shape during 
embryonic morphogenesis (Lecuit and Lenne, 2007; Vicente-Manzanares et al., 
2009). We hypothesized that these proteins also play an integral role in shaping 
the cells that contribute to the MHB tissue fold. In order to test this hypothesis we 
first determined the zebrafish homologs of human non-muscle myosin II proteins. 
Zebrafish have two homologs of human MYH9 (myh9a and myh9b) encoding for 
NMIIA, one homolog for MYH10 (myh10) which encodes for NMIIB, and one 
homolog for MYH14 (myh14), which encodes for NMIIC. According to the current 
zebrafish genome assembly, the sequence homology for myh9a and myh9b is 
77% and 79% respectively, compared to the human MYH9 (Flicek et al., 2013). 
Zebrafish myh10 is 90% similar to the human homolog, while myh14 is only 62% 
49 
 
 
 
similar to the human homolog. It has been demonstrated in the mouse that all three 
isoforms are expressed broadly throughout the embryo; however, there are tissues 
that express relatively higher levels of one isoform compared to others (Golomb et 
al., 2004). myh14 appears to have the lowest expression level in the developing 
mouse brain (Golomb et al., 2004), and has the lowest sequence homology from 
human to zebrafish; therefore, we did not investigate the role of NMIIC in cell shape 
changes during MHB morphogenesis in the zebrafish.  
Diagrams of the three zebrafish genes investigated in this study are shown (Fig. 
9A). Using RT-PCR we confirmed that all three genes were expressed 
embryonically during the time of MHB development (Fig. 9B). We further analyzed 
gene expression using in situ hybridization to determine the localization of 
expression within the developing embryo (Fig. 9C). We found low levels of 
expression for myh9a maternally (4 hpf) and at early stages (12 hpf). There was 
some localized expression of myh9a within the forebrain, eyes, and tail between 
18 and 24 hpf. Non-specific staining for myh9a was detected within the brain 
ventricle space and in the yolk in both antisense and sense controls. myh9a did 
not have obvious expression in the neuroepithelium of the MHB region during 
morphogenesis. myh9b was found to be expressed maternally (4hpf) and 
expression was detected throughout the whole embryo and brain at each time 
point analyzed. myh10 had a low level of maternal expression at 4 hpf; however, 
by 12 hpf myh10 was also found to be expressed throughout the whole embryo 
and brain. Together these data indicate that the zebrafish non-muscle myosin II 
genes myh9b and myh10 are expressed during the time of MHB morphogenesis 
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and are found throughout the embryo and brain. While myh9a is also expressed, 
it does not appear to be as highly localized to the brain or MHB region as myh9b 
or myh10 at these times. These data are consistent with the reported expression 
patterns for myh9 and myh10 during mouse embryonic development (Golomb et 
al., 2004). Next, we investigated the role for myh9a, myh9b, and myh10 in 
regulating the cell shape changes that are required for the formation of the MHB 
fold. 
Characterization of early MHB morphogenesis and cell shape changes 
In order to better characterize the initial tissue and cell shape changes that lead to 
the MHB tissue fold, we performed detailed analysis of wild type MHB development 
during early stages of MHB formation when cells are shortening (Gutzman et al., 
2008). We injected wild type embryos with membrane GFP (mGFP) mRNA and 
imaged the developing MHB in live embryos using scanning confocal microscopy 
at the somite stages indicated (Fig. 10). We quantified changes in the tissue over 
this time frame by analyzing tissue angle, cell length, and cell width. We found that 
the angle of the fold changes from 140 degrees to less than 100 degrees between 
18 and 24 somite stage (ss) (Fig. 10A-D). We found that cells at the MHBC shorten 
from 50 microns to less than 40 microns during this time frame (Fig. 10E). We also 
found that cells outside the MHBC get slightly shorter during this time; however, 
there is still a large difference in cell length at the MHBC compared to cells outside 
(Fig. 10F). By 24 ss cells at the MHBC are approximately 75% of the length of the 
outside cells (Fig. 10G) which is consistent with our previous findings (Gutzman et 
al., 2008). Importantly, we also discovered that the width of the cells changes 
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between 22 and 24 ss (Fig. 10H) and cells in the MHB region get narrower as the 
morphology of the MHB is changing and the MHBC is forming. 
myh9b and myh10 are required for MHB development 
In order to define the role for NMIIA and NMIIB in embryonic MHB morphogenesis, 
we conducted knockdown experiments using splice-site targeting, antisense 
oligonucleotide morpholino (MO) knockdown of myh9a, myh9b, and myh10. Splice 
targeting morpholinos were chosen due to the essential requirement for non-
muscle myosins during early development and cell division (Conti et al., 2004; Ma 
et al., 2007; Maciver, 1996; Urven et al., 2006). We were able to carefully titrate 
the concentration of each splice targeting morpholino to prevent abnormal levels 
of cell death while maintaining normal levels of cells division, which allowed us to 
determine the role for these proteins in regulating cell shape during 
morphogenesis. Splice blocking morpholinos were confirmed at the concentrations 
used for all of the experiments presented here using RT-PCR or Western blot 
analysis (Fig. S1).   
Embryos were injected with morpholinos at the one-cell stage and analyzed for 
gross embryonic phenotypes and for overall brain morphology at 24 ss using 
brightfield microscopy. Although we focused specifically on brain morphogenesis 
defects and cell shape changes at the MHB for this study, we did observe other 
gross phenotypes in morpholino injected embryos (Fig. S2). myh9b morphants 
demonstrated somite defects, abnormal tail curvature, pigmentation defects, heart 
abnormalities, slight edema, and abnormal eye and ear formation. myh10 
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morphants had abnormal body axis curvature, heart abnormalities, and abnormal 
eye development. myh9a morphants injected with our splice site targeting MO did 
not appear to have any observable gross morphology defects with the 
concentrations of morpholino tested (Fig. S2). This is in contrast to the studies by 
Muller et al. where they demonstrated that knockdown of myh9a (previously called 
zmyh9 and myh9-like2) using a MO targeting the 5’-untranslated region and 
translational start site, leads to abnormal development of the glomerulus and 
causes gross embryonic edema at 5 days post fertilization (Muller et al., 2011).  In 
those studies Muller et al. did not investigate the role of the other zebrafish myh9 
gene, myh9b (previously called myhz9 and myh9-like1). This difference in overall 
gross phenotype for myh9a knockdown between our studies and Muller et al. is 
likely due to the timing of phenotypic analysis, the nature of the morpholinos 
utilized, and their respective target sequences.  
Analysis of overall MHB morphology in control MO injected embryos at 24 ss 
showed normal formation of the MHB, visible with a clear and distinct fold in the 
tissue at the point of deepest constriction (MHBC) and normal openings in the 
midbrain and hindbrain ventricles (Fig. 11A). These results are consistent with our 
previous reports (Gutzman et al., 2008). A morpholino designed specifically to 
target only myh9a did not result in any visible abnormal MHB or brain phenotype 
when imaged with brightfield microscopy (Fig. 11B). In contrast, embryos injected 
with the myh9b MO or the myh10 MO had abnormal MHB development. myh9b 
morphants did not have a sharp fold in the tissue at the point of deepest 
constriction, instead the fold was a curved shape (Fig. 11C). myh10 morphants, 
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similar to myh9b morphants, failed to form a sharp tissue bend at the MHB (Fig. 
11D). myh10 morphants also had decreased midbrain ventricle opening (Fig. 11D). 
We have previously shown that abnormal brain ventricle inflation, due to lack of 
cerebrospinal fluid as found in the snakehead mutant, did not affect cell shape at 
the MHB (Gutzman et al., 2008). Therefore, the myh10 morphant ventricle defect 
is likely due to abnormal dorsolateral hinge-point formation which is also 
dependent on non-muscle myosin II (Nyholm et al., 2009). Knockdown of both 
myh9a and myh9b together, or myh9a and myh10 together, at the same 
concentration of morpholino used for single knockdown, did not worsen or change 
the MHB phenotype observed (data not shown). However, the double knockdown 
of myh9a and myh9b did appear to worsen the gross whole embryo tail and eye 
phenotypes at 24 ss, which is consistent with the localization of myh9a gene 
expression at this time point (data not shown). 
We rescued the 24 ss brain phenotypes in myh9b and myh10 morphants by co-
injection of human MYH9 or MYH10 mRNA (Fig. S3). Quantification and 
representative images are shown for normal, mild, and severe myh9b and myh10 
morphant phenotypes (Fig. S3). For all of the experiments presented here 
investigating MHB defects and cell shape analysis, only mild phenotypes were 
analyzed. This is consistent with the level of protein knockdown we detect using 
the myh10 morpholino, where our knockdown results in approximately 40% loss 
of the NMIIB protein (Fig. S1D). Together these data demonstrate that knockdown 
of both myh9b and myh10, but not myh9a knockdown, results in abnormal 
formation of the MHB indicating a role for myh9b and myh10 in brain 
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morphogenesis. More detailed and quantitative comparisons of the knockdown 
MHB phenotypes are described in the following sections. 
MHB tissue angle is dependent upon non-muscle myosin IIA and IIB 
After determining that knockdown for both myh9b and myh10 led to defects in MHB 
formation by brightfield microscopy, we wanted to determine the specific role for 
these non-muscle myosin proteins in regulating cell and tissue shape during 
morphogenesis. We performed detailed analyses on our non-muscle myosin II 
morphant brains and compared them to control morpholino injected embryos. We 
first examined the MHB tissue angle. Single-cell embryos were injected with MO 
and mGFP, and then imaged live using confocal microscopy. The angle at the 
MHBC was measured and compared (Fig. 11E-J). The average angle at 24 ss in 
control MO injected embryos was approximately 100 degrees.  myh9a morphants 
had a normal tissue angle; however, myh9b MO injected embryos had a broader 
tissue angle of 125 degrees, and myh10 MO injected embryos had an abnormal 
MHB tissue angle of 140 degrees (Fig. 11E-J). These results indicate that both 
myh9b and myh10 contribute to the formation of the tissue angle at the MHB. We 
also analyzed the tissue angle in mypt1 morphants. mypt1 is the regulatory subunit 
of myosin phosphatase and mypt1 knockdown results in non-functional myosin 
phosphatase and overactive non-muscle myosin II activity (Hartshorne et al., 
2004). In addition, our previous report demonstrated that mypt1 knockdown leads 
to abnormal tissue and cell shape in the hindbrain (Gutzman and Sive, 2010). With 
mypt1 knockdown, and therefore overactive NMIIA and NMIIB, we found that the 
mypt1 morphants also had an abnormal tissue angle with an average of 130 
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degrees at 24 ss (Fig. 11I-J). This result further supports the observation that 
regulation of non-muscle myosin activity is important for this morphogenetic 
process. 
Since non-muscle myosin II is known to be required for normal cell proliferation, 
we confirmed that the brain phenotypes observed were not a result of increased 
or decreased cell proliferation or cell death. We analyzed cell proliferation with PH3 
staining and cell death with TUNEL staining. We found that cell proliferation and 
cell death were normal in myh9b and myh10 morphants at the concentrations of 
MO used for these experiments (Fig. S4). Together, these results indicate that 
myh9b and myh10 have critical roles in determining the proper angle of tissue 
folding at the MHB, and that myh9a does not appear to be involved in this process. 
The mypt1 knockdown phenotype also confirms the importance of specific 
regulation of the contractile state of the NMII proteins during MHB morphogenesis.  
myh9b is required for cell shortening at the MHBC 
During MHB morphogenesis, the first cell shape change occurs between 17 and 
22 hours post fertilization (equivalent to 16 to 24 ss) where cells at the MHBC 
shorten to 75% of the length of cells outside of the MHBC (Fig. 10 and (Gutzman 
et al., 2008). The mechanisms that regulate cell shortening at the MHBC are 
unknown. We hypothesized that NMII proteins regulate this cell shape change 
which is required for the formation of the normal MHB tissue angle. We tested this 
hypothesis using knockdown experiments and then quantifying the length of the 
cells at the MHBC and outside of the MHBC (Fig. 12). Embryos were injected with 
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mGFP and specific morpholinos targeting myh9a, myh9b, myh10, or mypt1, and 
then live imaged at 24 ss using confocal microscopy. Cell length was quantified at 
the MHBC. At this stage of development neuroepithelial cells span the entire 
epithelium from apical to basal; therefore, we used the width of the single layer of 
pseudostratified epithelium as a measure of cell length. We measured cell length 
on one side of the neural tube at the MHBC (X) (Fig. 12A). Then we measured the 
length of cells 40 microns posterior to the MHBC (approximately 15 cells) outside 
of the MHBC region (Y) (Fig. 12B). We found that myh9b morphants had 
significantly longer cells at the MHBC compared to controls, while the length of the 
MHBC cells in myh9a and myh10 morphant cells were unchanged (Fig. 12C-G). 
In the surrounding region posterior to the MHBC we found that cell length in myh9b 
morphants was the same as control, but myh10 cells were slightly, but significantly, 
shorter (Fig. 12H). However, this small change in cell length outside of the MHBC 
from myh10 morphants would still not account for the dramatic angle change 
observed at the MHBC. 
At the MHBC, and outside of the MHBC, mypt1 morphant cells were shorter than 
control cells (Fig. 12F, H). This observation continues to support the role for mypt1 
in regulating myosin contraction. mypt1 morphants have overactive myosin, which 
causes increasing actomyosin contraction within the cells and leads to a 
shortening of the cells, consistent with the cell shape phenotype previously 
observed in the hindbrain (Gutzman and Sive, 2010).   
Together these data indicate that cell shortening at the MHBC is dependent upon 
the function of myh9b, and not myh10, suggesting a different role for these two 
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non-muscle myosin proteins in regulating cell shape changes during MHB 
morphogenesis.  
myh10 is required for regulating cell width in the MHB 
In our detailed analysis of wild type embryos we discovered that cells throughout 
the MHB region become narrower during the formation of the fold (Fig. 10). While 
conducting our knockdown experiments and confocal imaging, we noticed that 
cells of the MHB in some morpholino-injected embryos looked wider than in 
control-injected embryos. Therefore, we conducted additional quantification of cell 
shapes by determining cell width and area in the MHB neuroepithelium in 
knockdown embryos. Embryos were injected with mGFP and morpholinos, and 
then live imaged at 24 ss using confocal microscopy. We quantified cell width and 
cell area in cells at the MHBC and in the posterior part of the MHB (Fig. 13). We 
found that cells in the myh9a and myh9b morphants had normal cell width and 
area (Fig. 13A-C, F, G); however, cells from embryos injected with myh10 
morpholino had significantly increased cell width and area (Fig. 13D, F, G). mypt1 
morphants also had significant differences in cell area and width (Fig. 13E-G) as 
would be predicted by over activation of non-muscle myosin and as previously 
observed in the hindbrain (Gutzman and Sive, 2010). 
These data indicate that myh10, and not myh9b, is critical for the regulation and 
maintenance of cell width in the MHB region of the neuroepithelium. This further 
supports the differential role for myh9b and myh10 in regulating cell shape at the 
MHB.  
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Abnormal distribution of actin at the MHB with NMIIA and NMIIB knockdown 
The discovery that NMIIA and NMIIB have different roles in regulating cell shape 
changes at the MHB led us to ask, what are the mechanisms for this differential 
regulation? We have previously demonstrated that later in MHB formation (24 hpf) 
actin is enriched at the MHBC (Gutzman et al., 2008), and since we know that non-
muscle myosin proteins are actin motors, we asked whether or not the distribution 
of actin in our knockdown embryos was also differentially disrupted with NMIIA or 
NMIIB knockdown. 
Embryos were injected with the morpholino indicated, stained with phalloidin, and 
imaged using confocal microscopy to show actin localization in the MHB region 
(Fig. 14). We quantified the relative distribution of actin within the MHB in three 
regions. We determined the amount of actin within the neuroepithelium at the 
MHBC compared to the neuroepithelium outside the MHBC (Fig. 14A). We 
compared the amount of actin located apically at the midline of the neural tube 
compared to the amount of actin within the neuroepithelium at the apical edge of 
the MHBC cells (Fig. 14B), and we compared the amount of actin located on the 
basal side of the neural tube compared to the amount of actin within the 
neuroepithelium at the basal edge of the MHBC cells (Fig. 14C). These different 
regions of the neuroepithelium were used for comparison in B and C to more 
carefully address changes at the extreme apical or basal edges of the cells 
compared to just inside the adjacent neuroepithelium. We used the ratio of mean 
fluorescence intensity of actin staining in two regions within each embryo for 
comparison, shown by box 1 and box 2 (Fig. 14A-C). The actin mean intensity ratio 
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for box 1 was divided by box 2 in that given region. A ratio of 1 would indicate equal 
distribution of actin in box 1 and box 2. In control embryos there is approximately 
1.5 times more actin within the neuroepithelium at the MHBC compared to more 
posterior neuroepithelium. This reflects the actin distribution previously described 
(Gutzman et al., 2008). There is 2 times more actin localized to the apical region 
of cells compared to the adjacent apical side of the neuroepithelial cells, and there 
is 1.5 times more actin on the basal side of the epithelium compared to the adjacent 
basal side of the neuroepithelium in the region of the MHBC (Fig. 14A-C, G). When 
we investigated actin distribution with myh9b knockdown we found a decrease in 
actin localization within the MHBC neuroepithelium and apically, while basal actin 
was unchanged (Fig. 14D, G). With myh10 knockdown there was a significant 
decrease in actin localized to the MHBC neuroepithelium, apically, and basally 
indicating that actin in all areas of the MHBC cells was disrupted (Fig. 14E, G). 
mypt1 knockdown did not affect apical actin distribution, as previously reported in 
the hindbrain (Gutzman and Sive, 2010); however, actin within the MHBC 
neuroepithelium was disrupted, as was basal actin distribution (Fig. 14F-G). 
Together, the differences in actin distribution with myh9b knockdown compared to 
myh10 knockdown are consistent with myh9b and myh10 having differential effects 
on regulating the actin cytoskeleton and neuroepithelial cell shape changes at the 
MHBC. myh9b affected actin only in the neuroepithelium and apically at the 
midline, while myh10 affected actin within the neuroepithelium, apically, and 
basally. 
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Non-muscle myosin IIA and IIB protein localization 
We also hypothesized that NMIIA and NMIIB would be differentially localized within 
the cells which could in turn explain their ability to differentially regulate cell shape. 
In order to test this hypothesis we used antibody staining specific for either NMIIA 
or NMIIB to see their localization pattern within the MHB region (Fig. 15). We did 
not detect any obvious differences between NMIIA and NMIIB localization in 
control embryos (Fig. 15A-C). The localization pattern was consistent with what 
has been demonstrated in the mouse neural tube (Ma et al., 2007). We did, 
however, see changes in both NMIIA and NMIIB localization with mypt1 
knockdown where non-muscle myosin II proteins accumulated apically and basally 
in the neuroepithelium as seen previously for NMIIA (Fig. 15D and (Gutzman and 
Sive, 2010)). Interestingly, when we stained for NMIIA with knockdown of myh10 
we found a change in NMIIA localization from generally cytoplasmic and apical to 
more diffuse and basally localized (Fig. 15E). We also found a change in NMIIB 
localization with myh9b knockdown, again from mostly cytoplasmic to more diffuse 
with increased basal localization (Fig. 15F). No primary controls are shown to 
indicate the specificity of the staining (Fig. 15G-H). 
These data indicate that normally, the localization of NMIIA and NMIIB is 
overlapping within the neuroepithelium of the MHB region at this time, suggesting 
that the mechanism by which NMIIA and NMIIB are differentially regulating cell 
shape changes during brain morphogenesis is not due to differential localization, 
but likely due to differential regulation of activity. Furthermore, our analysis of 
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localization of one NMII protein with knockdown of other indicates that NMIIA and 
NMIIB depend on each other for proper localization. 
D. DISCUSSION 
myh9b and myh10 differentially regulate cell shape during MHB 
morphogenesis 
In wild type embryos, the basal angle of the MHB changes over time from 140 
degrees at 18 ss to a more acute angle of 95 degrees by 24 ss (Fig. 10). During 
this time, cells at the MHBC are changing shape to allow this angle to form. Cells 
at the MHBC shorten by approximately 25%, while cells outside the MHBC also 
shorten slightly over this time window (Fig. 10). Concurrently, cells throughout the 
MHB region become narrower between 22 ss and 24 ss (Fig. 10). Together these 
morphogenetic changes lead to the formation of the highly conserved MHB fold 
(Fig. 16A). 
Here, we demonstrate for the first time that non-muscle myosin IIA and IIB have 
distinct roles in regulating cell shape changes during brain morphogenesis. We 
discovered that NMIIA is required for the shortening of the cells specifically at the 
MHBC, while NMIIB is required for the narrowing of the cells throughout the MHB 
region (Fig. 16B and C). In contrast to our knockdown studies, we investigated 
non-muscle myosin II gain of function using mypt1 knockdown. We found that cells 
in mypt1 morphants, where there is over activation of non-muscle myosins, were 
both shorter and wider cells throughout the MHB region (Fig. 16D), which is 
consistent with the cell shape phenotype found with mypt1 loss of function in the 
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hindbrain (Gutzman and Sive, 2010). Together, these data demonstrate that NMIIA 
is required for regulating the length of cells specifically at the MHBC and not in 
surrounding regions, while NMIIB is required for regulation of cell width throughout 
the MHB region. This uncovers a novel differential role for mechanisms by which 
these two proteins regulate cell shape during brain morphogenesis. 
Cell length and cell width during development 
Morphogenetic processes require specific changes in cell shape to cause bending 
of epithelial sheets, tissue invagination, and tube formation. We propose that 
regulating cell length and cell width may be as important in developmental 
processes as apical constriction or cell migration; however, investigation and 
quantification of these more subtle changes in cell shape has been limited. Apical 
constriction results in decreased surface area on the apical side of the polarized 
cell changing shape, and is critical in development during gastrulation and 
vertebrate neural tube formation (Haigo et al., 2003; Lee and Harland, 2007; Martin 
et al., 2009). Various mechanisms of apical constriction have been described 
depending on cell type and context, typically involving apical actomyosin networks 
linked to cell-cell apical junctions (Martin and Goldstein, 2014). Other cell shape 
changes including changes in cell length, width, or basal constriction have been 
less well defined and are likely to be regulated via both overlapping and distinct 
mechanisms. For example, during neural tube formation, cells of the neural plate 
have been described to lengthen before they apically constrict (Karfunkel, 1974), 
and although this cell shape change has been defined for decades, the mechanism 
for this cell lengthening has not been studied. Distinct mechanisms have been 
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uncovered for regulation of basal constriction. We determined that basal 
constriction at the MHB, following cell shortening, is laminin dependent, and basal 
constriction in optic cup morphogenesis requires the novel gene ojoplano  
(Gutzman et al., 2008; Martinez-Morales et al., 2009; Wang et al., 2012). In 
contrast, follicle cells in drosophila egg chamber elongation are regulated by 
actomyosin contraction, as in apical constriction; however, the orientation of the 
filaments is different and the contraction occurs basally, not apically, to shape the 
tissue (He et al., 2010).  
The Kupffer’s vesicle also undergoes regional cell shape changes during 
development. Interestingly, in the Kupffer’s vesicle the anterior cells are elongated 
and the posterior cells shorten and widen over time (Wang et al., 2012), cell shape 
changes that are similar to those described here for MHB morphogenesis. 
Furthermore, these cell shape changes are regulated by non-muscle myosin II 
activity (Wang et al., 2012); however, it was not determined if NMIIA and NMIIB 
had distinct functions in the shortening or widening of cells. Future experiments to 
determine the mechanisms that regulate cell shape changes such as length, width, 
and basal constriction are essential for understanding complex morphogenetic 
processes. 
Function of NMIIA versus NMIIB  
The DNA sequence and protein structural similarities between NMIIA and NMIIB 
might suggest that these proteins are redundant; however, it is becoming more 
apparent that each isoform has distinct functions. The function of these proteins 
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has been determined using knockdown studies in many systems. NMIIA and 
NMIIB knockout mice display different phenotypes, where NMIIA knockouts are 
embryonic lethal due to cell adhesion defects (Conti et al., 2004), and NMIIB 
knockouts  present with heart, brain, and neuronal migration defects (Ma et al., 
2007; Ma et al., 2004).  The ablation of NMIIB in mice resulted in structural 
abnormalities in the brain of mice, consistent with the role for NMIIB neuroepithelial 
morphogenesis (Tullio et al., 2001). Experiments to test for functional redundancy 
between NMIIA and NMIIB have suggested only a limited ability for the proteins to 
compensate for each other. For example, replacement of NMIIB with NMIIA in the 
mouse rescues brain abnormalities, but does not rescue cardiac defects (Bao et 
al., 2007).  Here we have uncovered new isoform-distinct functions in regulating 
cell shape at the MHB during brain morphogenesis. 
NMIIA and NMIIB have different enzymatic properties during ATP-hydrolysis, 
which determine their distinct roles in regulating cell shape. Only a small fraction 
of the head domain of NMIIA is strongly bound to actin at any one time (Kovacs et 
al., 2003). In contrast, NMIIB is one of the slowest myosins with regard to the rate 
in which it translocates actin filaments by having a slow ATPase cycle; therefore it 
spends a significantly longer time strongly bound to actin (Wang et al., 2003). This 
longer binding may make NMIIB better suited for maintaining cellular tension. 
These differences in enzymatic activity may account for the role of NMIIB in 
regulating cell width and area throughout the MHB region, while NMIIA is working 
more quickly to shorten cells in a specific brain region. 
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Differential regulation of NMIIA and NMIIB 
We determined that NMIIA and NMIIB proteins are not differentially distributed 
within the cells at the MHB; however, we did discover that knockdown of one can 
influence the localization of the other (Fig. 15). NMIIA and NMIIB are both activated 
via phosphorylation of the myosin regulatory light chain (MRLC) (Bresnick, 1999; 
Ito et al., 2004). Yet, NMIIA and NMIIB are differentially regulating cell shape in the 
same cell resulting in distinct changes. From our previous work, we know that the 
level of phosphorylated MRLC in the brain increases from 18 hpf to 21 hpf and 
then goes back down by 24 hpf (Gutzman and Sive, 2010), indicating the NMII 
activity is high in the brain during the time of morphogenesis investigated here. 
MRLC activation can occur via multiple signaling pathways; including via myosin 
light chain kinase (MLCK) and/or Rho-kinase (ROCK). In cell culture, MLCK and 
ROCK specifically localize to regulate MRLC phosphorylation in a spatially 
dependent manner. In 3T3 cells, ROCK is more active in phosphorylating MRLC 
at the center of the cell, while MLCK is more active in phosphorylating MRLC at 
the cell periphery (Totsukawa et al., 2004; Totsukawa et al., 2000). It was 
demonstrated in migratory cells that a given cellular microenvironment may play a 
role in determining the localization and function of specific NMII isoforms (Raab et 
al., 2012). Although we do not see a difference in NMIIA and NMIIB localization in 
normal tissue here, potentially the differential function of the two proteins is 
determined by differential localization of their upstream activators which have yet 
to be identified. Another possibility is that, although the proteins are localized in 
the same parts of the cell, the orientation of the non-muscle myosin heavy chains 
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may be oriented in opposing directions. For example, NMIIA fibers may run in an 
apical to basal direction to regulate cell length, while NMIIB fibers may orient 
perpendicularly to NMIIA to regulate cell width.   
Non-muscle myosin heavy chains IIA and IIB can both be phosphorylated on 
various sites to affect filament assembly and protein function (Vicente-Manzanares 
et al., 2009). This raises the question as to whether or not there is a difference in 
the phosphorylation state of the non-muscle myosin heavy chains themselves at 
the MHB. Phosphorylation of the NMII heavy chains facilitates filament 
disassembly and NMIIA and NMIIB have different sites in their tail domains making 
this a possible level of differential activation and regulation. It was also recently 
demonstrated that NMII isoforms can co-assemble in living cells, forming 
heterotypic filaments that can perform both isoform specific and redundant 
functions (Beach et al., 2014). It remains to be seen if these heterotypic filaments 
are present in the neuroepithelium during development.  
Differential distribution of actin with non-muscle myosin knockdown 
It is established that NMII protein activity, in response to extra or intra-cellular 
signals, contributes to the spatial organization of the actin network, resulting in 
contractility and physiological functions (Kohler et al., 2011). Both NMIIA and 
NMIIB knockdown resulted in abnormal actin distribution in the MHB region during 
morphogenesis. Knockdown of NMIIA caused changes in actin localization within 
the neuroepithelium and at the apical surface of the neural tube, while knockdown 
of NMIIB caused abnormal actin distribution within the neuroepithelium, and at 
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both the apical and basal surfaces of the neural tube. The location of actin affected 
by NMII knockdown may provide some additional clues as to the regulation of the 
NMII protein. Since mypt1 appears to regulate NMII activity apically, it is likely to 
be regulating both NMIIA and NMIIB (Gutzman and Sive, 2010), which is 
consistent with the mypt1 knockdown cell shape phenotypes as well. Actomyosin 
activity is regulated on the basal surface of follicle cells by Rho, ROCK, and cell-
cell adhesion during Drosophila egg chamber development to cause contraction 
(He et al., 2010). However, Drosophila have only one non-muscle myosin heavy 
chain (zipper), indicating the importance for in vivo vertebrate studies to determine 
how NMIIA and NMIIB are differentially regulating cell shape. These studies will 
be essential to elucidate additional mechanisms of morphogenetic processes. 
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Figure 9. myh9a, myh9b, and myh10 are expressed during the time of MHB 
morphogenesis. (A) Diagram of the zebrafish myh9a, myh9b, and myh10 genes. 
Domain regions are highlighted. Regions amplified for RT-PCR time course 
expression are shown with arrows (primer details can be found in “Materials and 
Methods”). Asterisks indicate the regions of the full length myh9a and myh9b in 
the current Ensembl zebrafish genome that have not been completely annotated. 
(B) RT-PCR analysis of myh9a, myh9b, and myh10 over a time course of 
embryonic development spanning MHB morphogenesis. EF1α was used as a 
control. Primer locations are indicated in panel A. (C) Time course of gene 
expression by in situ hybridization for myh9a, myh9b, and myh10 in the developing 
embryo from 4 hpf- 24 hpf. Each gene is shown with the antisense probe 
expression pattern and sense control.  
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Figure 10. Quantification of wild type tissue and cell shape changes during 
MHB morphogenesis between 18 and 24 ss. (A-C) Live confocal imaging of wild 
type embryos injected with mGFP and imaged at the stages indicated. (A’-C’) 
Magnifications of images in A-C with individual cells outlined at the MHBC and 
posterior to the MHBC towards the hindbrain. (D) Quantification of the MHB angle 
on the basal side of the neuroepithelium (see dotted lines in A-C). (E) 
Measurement of neural tube width as a representation of cell length in cells at the 
MHBC over time. (F) Measurement of neural tube width as a representation of cell 
length in cells 40 microns posterior to the MHBC over time. (G) Changes in the 
percentage of cell shortening for cells at the MHBC compared to cells 40 microns 
outside the MHBC over time. (H) Quantification of cell width measurements over 
time. Arrowheads indicate MHBC. Asterisks in A-C indicate cells outlined in the 
images below (A’-C’). One-way ANOVA with multiple t-test comparisons was 
performed to determine significance, asterisks indicate p<0.001. Results are 
shown as ± s.e.m. 18 ss; n = 9; 22 ss, n = 11, 24 ss, n = 11. Scale bars: 25 µm. 
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Figure 11. myh9b, myh10 and mypt1 are required for MHB tissue 
morphogenesis. (A-D) Brightfield dorsal view images of 24 ss embryos following 
injection with (A) control MO, (B) myh9a MO, (C) myh9b MO, (D) myh10 MO. 
Anterior is to the left in all images. Arrowheads indicate MHBC. Scale bars: 100 
µm. (E-I) Live confocal images showing the MHB region of 24 ss zebrafish 
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embryos injected with mGFP mRNA and coinjected with control MO (E), myh9a 
MO (F), myh9b MO (G), myh10 MO (H), or mypt1 MO (I). (J) Quantification of the 
MHB angle on the basal side of the neuroepithelium (see angle lines in E-I). One-
way ANOVA with multiple t-test comparisons was performed to determine 
significance between control and test groups. Asterisks indicate p<0.001. Results 
are shown as ± s.e.m. For E-I; control MO, n = 48; myh9a MO, n = 10; myh9b MO, 
n = 16; myh10 MO, n = 18; mypt1 MO, n = 20. 
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Figure 12. myh9b is required for cell shortening at the MHBC during 
morphogenesis. (A-F) Live confocal images showing the MHB region of 24 ss 
zebrafish embryos injected with mGFP and coinjected with control MO (A-B), 
myh9a MO (C), myh9b MO (D), myh10 MO (E), or mypt1 MO (F). (G) 
Quantification of the cell length (X) at the MHBC (see lines in A, C-F). (H) 
Quantification of cell length 40 microns outside of the MHBC (Y) (see lines in B-F). 
One-way ANOVA with multiple t-test comparisons was performed to determine 
significance between control and test groups. Asterisks indicate p<0.001. Double 
asterisks indicate p<0.05. Results are shown as ± s.e.m. Control MO, n = 48; 
myh9a MO, n = 10; myh9b MO, n = 16; myh10 MO, n=18; mypt1 MO, n=20. Scale 
bars: 25 µm. 
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Figure 13. myh10 is required for regulation of cell width in the MHB during 
morphogenesis. (A-E) Live confocal images showing one side of the MHB region 
of 24 ss zebrafish embryos injected with mGFP and coinjected with control MO 
(A), myh9a MO (B), myh9b MO (C), myh10 MO (D), or mypt1 MO (E). Single 
representative cells are outlined in each panel. (F) Quantification of the cell width. 
(G) Quantification of cell area. One-way ANOVA with multiple t-test comparisons 
was performed to determine significance between control and test groups. 
Asterisks indicate p<0.001. Double asterisks indicate p<0.05. Results are shown 
as ± s.e.m. For each embryo (n) a total of 6 cells were outlined: 2 cells at the MHBC 
were outlined, 2 cells 40 microns posterior to the MHBC were outlined, and 2 cells 
within the 40 micron region between the MHBC and posterior were outlined. Cells 
were chosen based on the ability to see an entire cell from apical to basal in a 
single z-section. Control MO, n = 9; myh9a MO, n = 9; myh9b MO, n = 14; myh10 
MO, n=9; mypt1 MO, n=9. Scale bars: 25 µm. 
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Figure 14. Actin distribution is dependent upon non-muscle myosin II 
function. (A-F) Embryos were injected as indicated and stained with phalloidin 
(green) to determine actin localization and regional enrichment. (A-C) Control 
morphant embryos with normal actin distribution at the MHB. Boxes indicate areas 
of comparison for determining the mean actin intensity ratio. (A) Comparison of 
actin intensity with the neuroepithelium at the MHBC region (box 1) compared to 
the posterior MHB (box 2). (B) Comparison of actin intensity apically at the midline 
(box 1) compared to the apical region within the neuroepithelial tissue (box 2). (C) 
Comparison of actin intensity on the basal side of the neuroepithelium (box 1) 
compared to the basal region within the neuroepithelial tissue (box 2). (G) 
Quantification of actin distribution comparison ratios for control MO, myh9b MO, 
myh10 MO, and mypt1 MO injected embryos in the regions indicated. One-way 
ANOVA with multiple t-test comparisons was performed to determine significance 
between control and test groups. Results are shown as ± s.e.m. Asterisks indicate 
significance compared to control, p<0.001. Double asterisks indicate, p<0.01. 
Arrowheads indicate MHBC. Control MO, n = 8; myh9b MO, n = 12; myh10 MO, 
n=13; mypt1 MO, n=8.  
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Figure 15. Non-muscle myosin IIA and IIB protein localization. (A-C) NMIIA 
and NMIIB antibody staining in 24 ss embryos injected with control MO.  (A) NMIIA 
antibody (green), (B) NMIIB antibody (red), (C) overlay of A and B. (D) Overlay of 
NMIIA and NMIIB immunostaining in a 24 ss mypt1 MO injected embryo. (E) NMIIA 
staining with myh10 MO knockdown. (F) NMIIB staining with myh9b MO 
knockdown. (G-H) No primary control from Alexa 488 and Alexa 555 secondary 
antibodies. Results are representative of at least three independent experiments. 
Control MO, n = 8; mypt1 MO, n = 7; myh10 MO, n = 14; myh9b MO, n = 19; Alexa 
488 no primary control, n = 5; Alexa 555 no primary control, n = 5.  
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Figure 16. Model for non-muscle myosin IIA and IIB differential regulation of 
cell shape changes at the MHB during brain morphogenesis. (A) 
Representation of a wild-type or control morphant embryo at 24 ss with 
magnification of the MHB region and simplified model of cell shape at the MHB. 
Wild-type and control morphants have an MHB angle of approximately 100 
degrees and cells at the MHBC are almost 25% shorter than surrounding cells, 
while all cells have equal cell width. (B) myh9b knockdown results in an increase 
in the MHB angle to 125 degrees and this angle difference is due to cells 
specifically at the MHBC not shortening normally. (C) myh10 loss-of-function 
results in an increase in the MHB angle to 140 degrees as a result of increase in 
cell width with normal cell length at the MHBC. (D) mypt1 knockdown, and 
increased activation of both NMIIA and NMIIB, results in both shorter and wider 
cells throughout the region leading to an increase in the MHB angle to 130 
degrees. 
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Supplemental Materials 
Figure S 1. Details for morpholino induced splice variation and sequence 
analysis. Single cell embryos were injected with 4ng control MO + 4ng p53 MO, 
4ng myh9a MO, 3ng myh9b MO + 3ng p53 MO, or 3ng myh10 MO. All MO 
confirmation experiments were conducted using the same concentration of MO as 
was used for all imaging and analysis experiments described in the “Materials and 
Methods”. RNA was collected from control and experimental morphant injected 
embryos at 24 hpf for RT-PCR analysis. For each MO used, aberrant splicing was 
detected, as well as a decrease in wild-type transcript. EF1α was used as a control 
for each RT-PCR experiment. (A) Analysis from RT-PCR experiments confirmed 
that injection of 4ng of myh9a MO resulted in an inclusion of intron 1-2. Wild-type 
transcript was detected in both control and myh9a morphants using the following 
primers, myh9a forward primer 1 (within Exon1) (5’-AAATTCAGCAAGGTG 
GAGGA-3’); myh9a reverse primer 1 (within Exon4) (5’-TTGGTGTTTTCGGTTT 
TTCC-3’). Aberrant splicing and the inclusion of intron 1 was detected only in the 
myh9a morpholino injected embryos using the following primers; myh9a forward 
primer 2 (within intron 1-2) (5’-tgcaaacttgagctttgtgtt-3’) and myh9a reverse primer 
2 (within Exon 8) (5’-GCACGGGACTTCTCCAATAG-3’). Diagram depicts location 
of primers, morpholino target, and abnormal splicing product with MO injection. (B) 
RT-PCR analysis confirmed that injection of 3ng of myh9b MO disrupts normal 
RNA processing. The myh9b MO caused three abnormal splice changes; a 
deletion of Exon 6, and two different length inclusions of intron 6-7. In addition, 
while investigating the effect of the myh9b morpholino on mRNA splicing, upon 
sequencing RT-PCR products following MO injection, we discovered an 
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unannotated putative exon between the current Ensembl annotation of Exon 5 and 
Exon 6 which we have termed Exon 5a. Initial experiments to test for aberrant 
splicing were conducted using the following primers: myh9b forward primer 1 
(within Exon 3) (5’-GGTGAATCTGGAGCTGGAAA-3’), and myh9b reverse primer 
1 (within Exon 8) (5’-TGTGGAAGGTTCGCTCTTCT-3’). Using these primers we 
discovered that our control samples consistently amplified two bands that were 
very close in size. Upon sequencing of both control bands, and myh9b MO RNA 
samples, we determined that we had discovered an additional unannotated exon 
that we have termed Exon 5a. For further testing of the morpholino activity we 
designed a primer to the Exon5a sequence which allowed us to clearly define the 
splice changes induced by the myh9b MO without multiple bands for each aberrant 
splicing product. The short Exon 5a sequence (previously annotated as intron) is 
as follows:  “AGCAGCTCCGTCCTGTCA CATGGT”. Primers used for the analysis 
presented in panel B include: myh9b forward primer 2 (within Exon5a) (5’-
GCAGCTCCGTCCTGTCAC-3’); myh9b reverse primer 1 (within Exon 8) (5’-
TGTGGAAGGTTCGCTCTTCT-3’). Diagram depicts location of primers, 
morpholino target, Exon 5a, and abnormal splicing products found with MO 
injection. (C) RT-PCR analysis confirmed that injection of 3ng of the myh10 MO 
causes a deletion of exon2.  myh10 forward primer: (within Exon 1) (5’-CTTC 
TGAACGGCATGGATTT-3’), myh10 reverse primer: (within Exon7) (5’-TTGGCAT 
TTCCAAAGGATTC- 3’). Diagram depicts location of primers, morpholino target, 
and abnormal splicing product with MO injection. Each abnormal splice variant 
from these morpholino injections resulted in a frame shift and the introduction of 
an early stop codon. (D) Representative Western blot for analysis of myh10 MO 
knockdown. Wild-type embryos were injected with control or myh10 MO as 
described above. At 24 ss the yolk was manually removed from the whole embryo 
and the whole tissue protein was isolated with a protease inhibitor cocktail (Roche, 
04693124001) as previously described (Gutzman and Sive, 2010). Antibodies 
include, anti-myosin IIB antibody (Santa Cruz Biotechnology, sc-376942, 1:500), 
anti-α-tubulin (Sigma-Aldrich, T6199, 1:2000), anti-mouse IgG HRP-linked 
antibody (Cell Signaling Technology Inc., #7076, 1:2000). Blots were imaged using 
Foto/Analyst Luminary FX imager with Foto/Analyst PC Image software (Fotodyne 
Inc.). Protein levels were quantified and compared with the α-tubulin controls using 
Photoshop from four independent experiments. 
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Figure S 2. Whole embryo phenotypes for morpholino injected embryos. 
Single cell embryos were injected with (A,B) 4ng control MO + 4ng p53 MO, (C,D) 
4ng myh9a MO, (E,F) 3ng myh9b MO + 3ng p53 MO, or  (G,H) 3ng myh10 MO. 
Live embryos were imaged using brightfield microscopy at 24 ss and at 48 hpf as 
indicated. myh9a morphants did not demonstrate any obvious phenotypes at the 
times imaged. For myh9b and myh10 morphants, representative mild phenotypes 
are shown. myh9b morphants demonstrated somite defects, abnormal tail 
curvature, pigmentation defects, heart abnormalities, slight edema, and abnormal 
eye and ear formation. myh10 morphants had abnormal body axis curvature, heart 
abnormalities, slight edema, and abnormal eye development. 
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Figure S 3. Rescue of the myh9b and myh10 knockdown MHB phenotype 
with human mRNA injection. Embryos were injected at the one cell stage with 
human MYH9 or MYH10 mRNA in conjunction with morpholino injections. The 
human full length DNA for MYH9 was obtained from Addgene clone 10844 and 
subcloned into the pCS2+ vector for mRNA expression. Human full length DNA for 
MYH10 was obtained from Addgene clone 10845 and subcloned into the pCS2+ 
vector for mRNA expression. mRNA was transcribed using the mMessage 
mMachine kit (Ambion). Graphs depict the distribution of “normal”, “mild”, and 
“severe” MHB phenotypes at 24 ss for each treatment group shown. (A) Embryos 
injected with myh9b MO combined with human MYH9 mRNA showed partial 
81 
 
 
 
rescue of the MHB phenotype. Control MO + mGFP, n=140; myh9b MO + mGFP, 
n= 148; myh9b MO + MYH9 mRNA, n=157. (B-D) Representative images 
demonstrating the “normal”, “mild”, and “severe” myh9b MO phenotypes scored. 
(E) Rescue of myh10 MO injected embryos with human MYH10 mRNA. Embryos 
injected with myh10 MO combined with human MYH10 mRNA showed partial 
rescue of the MHB phenotype. Control MO + mGFP, n= 90; myh10 MO + mGFP, 
n= 106; myh10 MO + MYH10 mRNA, n=120. (F-H) Representative images 
demonstrating the “normal”, “mild”, and “severe” myh10 MO phenotypes scored. 
For myh9b MO rescue 100 pg of MYH9 mRNA was co-injected, and for myh10 
MO rescue 200 pg of MYH10 mRNA was co-injected. Chi-squared test with a 3X3 
contingency table (df=4) was performed to test for statistical significance between 
the three treatment groups and the number of embryos with normal, mild, or severe 
phenotypes. For panel A (myh9b rescue data) Chi-squared = 206.79, p<0.00001. 
For panel E (myh10 rescue data) Chi-squared = 144.04, p<0.00001. 
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Figure S 4. myh9b and myh10 knockdown does not affect cell proliferation 
or cell death at the MHB.  (A-C) Representative confocal images of control (A), 
myh9b MO (B), and myh10 MO (C) injected embryos that were fixed at 24 ss and 
stained with PH3 (green) to label proliferating cells. Embryos were fixed in 4% 
PFA, deyolked, rinsed in PBT and blocked overnight in (2% NGS, 2% BSA, 1% 
DMSO, 0.5% TritonX in PBS). Embryos were incubated in primary anti-PH3 
antibody, (Millipore, 1:800) overnight, washed, and incubated in secondary 
antibody Alexa Fluor 488 (goat anti rabbit, 1:500). Propidium iodide was used to 
stain for nuclei (Invitrogen, P3566, 1:1000 in PBT) for 1 hour. Embryos were 
washed, mounted in glycerol and imaged using Nikon CS2 laser scanning confocal 
microscope. Boxes indicate the region of the brain where total cell number and 
PH3 positive cells were counted within the neural tissue. (D) Quantification of the 
percentage of PH3 positive cells within the region. Control MO, n=22; myh9b MO, 
n=14; myh10 MO, n=10. Results are shown as mean ± s.d. No significant 
differences were detected. (E-G) Representative confocal images of control (E), 
myh9b MO (F), and myh10 MO (G), injected embryos that were fixed at 24 ss and 
TUNEL labeled (green) to indicate apoptotic cells. All embryos were counter 
stained with propidium iodide (red) to label all cells.  Apoptosis was detected by 
the TUNEL method using the Apoptag Kit (Millipore) according to the provided 
protocol using fluorescent detection of apoptotic cells. Embryos were 
counterstained with propidium iodide to label nuclei and imaged by laser-scanning 
confocal microscopy (Nikon CS2). Boxes indicate the region of the brain where 
total cell number and TUNEL positive cells were counted within the neural tissue. 
(H) Quantification of the percentage of TUNEL positive cells within the region. 
Control MO, n=10; myh9b MO, n=14; myh10 MO, n=10. Results are shown as 
mean ± s.d. No significant differences were detected. 
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CHAPTER 3 
CALCIUM REGULATES CELL LENGTH DURING 
ZEBRAFISH MIDBRAIN-HINDBRAIN BOUNDARY 
DEVELOPMENT 
A. INTRODUCTION 
Calcium signaling plays a vital role in various developmental processes including 
gastrulation and establishment of body axis (Gilland et al., 1999; McGrath et al., 
2003). It promotes airway branching morphogenesis in the developing lung 
(Brennan et al., 2013) and is important in neuronal development in axonal and 
dendritic morphogenesis (Ramakers et al., 2001).  Calcium is also involved in 
cellular morphogenesis. Influx of extracellular calcium is required for epithelial cell 
contraction in carcinoma cell lines (Lee and Auersperg, 1980) and it plays an 
important role in cell shape change in platelets and endothelial cells (Moore et al., 
1998; Porter et al., 2003). Thus, calcium is involved in many developmental and 
cellular morphogenetic events.  
In order for calcium signaling to promote morphogenesis, it must act on 
downstream effectors of cell shape such as cytoskeletal elements. Gastrulation, 
dorsal closure and egg chamber elongation are some developmental events that 
are separately known to be regulated by calcium and non-muscle myosin II (NMII) 
(Franke et al., 2005; Hunter et al., 2014; Tada and Concha, 2001). Calcium 
signaling has been classically studied to regulate NMII activity in skeletal and 
smooth muscle contraction (Porter et al., 2003; Somlyo and Somlyo, 2003; Szent-
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Gyorgyi, 1975). Some studies have indicated this interaction to be mediated by 
myosin light chain kinase (Martinsen et al., 2013; Watanabe et al., 2001).  
Using the zebrafish midbrain-hindbrain boundary (MHB) as a model to study 
epithelial brain morphogenesis, we previously characterized the cell shape 
changes that occur during MHB formation. We found that the cell shape changes 
are regulated by non-muscle myosin II (NMII) proteins (Gutzman et al., 2015 and 
chapter 2) and NMII activity depends on the phosphorylation state of the myosin 
light chain (MLC) (Gutzman et al.,2010). The myosin phosphatase holoenzyme 
dephosphorylates the MLC, and is regulated by the Mypt1 inhibitory regulatory 
subunit. We have shown that mypt1 morphants have an abnormal MHB, due to an 
overactivation of NMII and a cell shape phenotype of shorter and wider cells in the 
MHB region (Gutzman et al., 2015 and chapter 2). The molecules directly affecting 
the phosphorylation state of NMII are in turn regulated by upstream signaling 
pathways which are yet to be elucidated. 
In the current study, we hypothesized that the calcium signaling pathway regulates 
NMII during zebrafish MHB formation. We found that calcium is required for proper 
MHB development in zebrafish and depletion of intracellular calcium release from 
the endoplasmic reticulum (ER) by treatment with the pharmacological inhibitor, 2-
aminoethoxy phenyl borate (2-APB) showed that the cells at the MHB constriction 
(MHBC) do not shorten normally. We further discovered that the cell length 
phenotype seen in mypt1 morphants can be rescued by inhibition of intracellular 
calcium release. Overactivation of NMII by mypt1 knockdown leads to shorter 
MHBC cells while inhibition of calcium release results in longer MHBC cells. 
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Successful rescue of the mypt1 phenotype by calcium inhibition suggests that both 
molecules may be part of the same signaling pathway regulating the formation of 
the zebrafish MHB. Thus, teasing apart this pathway can help in improving our 
understanding of similar mechanisms involved in other developmental 
morphogenetic events.   
B. MATERIALS AND METHODS 
Animals 
Wild-type AB zebrafish were raised and staged according to standard protocols as 
previously described (Kimmel et al., 1995). Embryos were staged according to 
somite stage (ss) for accuracy. 18 ss is 18 hpf and 24 ss is 22 hpf.  
Microinjections 
Splice-site blocking morpholino antisense oligonucleotides were injected at one-
cell stage with a co-injection of membrane GFP (mGFP) at a concentration of 200 
ng/µl. mGFP allows visualization of individual cell outlines during confocal imaging. 
Mypt1 MO (5-ATTTTTTGTGACTTACTCAGCGATG-3; Gene Tools) that targets 
exon 2-intron 2 of the zebrafish mypt1 was used at a concentration of 5 ng/µl 
(Gutzman and Sive, 2010). A standard control MO (5-CCTCTTACCTCAG 
TTACAATTTATA-3) and p53 morpholino (5-GCGCCATTGCTTTGCAAGAATTG-
3) were also used at equivalent concentrations of 5 ng/µl (Gene Tools).  
Drug treatments  
Embryos were treated with 2-aminoethoxy phenyl borate (2-APB, Sigma D9754-
1G) at 18 ss for 10 minutes at a concentration of 100 µM from a stock solution of 
100 mM, and washed in 1X Danieau’s solution.  
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Calcium imaging 
Calcium green-1 dextran (Invitrogen molecular probes C3714) and dextran 
tetramethyl rhodamine (Invitrogen molecular probes D1818, 70000 MW) were 
injected into embryos at one-cell stage. At 4 hpf, they were manually 
dechorionated and placed on a glass slide in 0.1% DMSO prepared in 1X 
Danieau’s solution for 10 minutes. Time lapse confocal images were taken once 
every 10 seconds for 10 minutes to detect calcium signals. The same embryo was 
imaged again by replacing the solution with 100 µM 2-APB prepared in 1X 
Danieau’s solution after a 10 minute treatment. Changes in fluorescence intensity 
in individual cell regions were quantified using the NIS Elements analysis software 
(Nikon). 
Western blotting 
Wild-type AB embryos were treated with the pharmacological inhibitor 2-APB at 
100 µM for 10 minutes at 18 ss. Following morpholino and drug treatment, while in 
the drug, embryos were dissected posterior to the ear to collect the head portion 
in a buffer containing Tris (pH 8.0), 10% glycerol, 1% Triton X-100 and protease 
inhibitor cocktail (Roche- 04693124001). Using a syringe, protein was extracted in 
lysis buffer and the concentration was estimated using the Bradford assay. 40 µg 
protein was analyzed by Western blotting. Primary antibody pMLC (Cell signaling 
#3671) was used at a concentration of 1:1000 and control primary antibody 
HDAC1 (Abcam ab41407) was used at 1:500. Secondary antibodies, anti-mouse 
HRP (Cell signaling technologies #7076S) and anti-rabbit HRP (Cell signaling 
technologies #7074S), were used at a dilution of 1:2000. PVDF membranes were 
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developed using the Supersignal West Femto maximum sensitivity substrate 
(Thermoscientific #34095) or the clarity Western ECL substrate (Bio-rad 
technologies #170-5060). Blots were imaged using a Foto/Analyst FX Imager with 
Foto/Analyst PC Image software (Fotodyne Inc.) or a Biospectrum 810 imager 
system (UVP, LLC), and quantified on Photoshop. 
Imaging and analysis 
Brightfield images were taken using an Olympus SZX12 stereomicroscope with an 
Olympus DP72 camera. Live embryo confocal imaging was carried out as 
previously described using Nikon CS2 laser scanning confocal camera and Nikon 
Elements software (Gutzman et al., 2015 and Chapter 2). Cell shapes were 
measured and analyzed using Nikon Elements Software, as previously described 
(Gutzman et al., 2015 and Chapter 2). 
Statistical analysis 
Statistical analysis was carried out using the Mann-Whitney U-test. This test was 
used to determine significance between two groups of data (control and treatment 
group) having unequal sample sizes (n). p-values denoting significance are 
reported for each experiment within the figure legend. 
C. RESULTS 
Calcium regulates cell length at the MHBC 
To investigate the potential role of calcium signaling in zebrafish MHB 
development, we utilized the pharmacological drug, 2-aminoethoxy diphenyl-
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borate (2-APB), that inhibits the IP3 receptor (IP3R) present on the endoplasmic 
reticulum (ER), preventing it from opening the calcium channel and consequently 
inhibiting the release of calcium into the cytosol (Ma et al., 2001; Taylor and Tovey, 
2010). We treated zebrafish embryos at 18 ss, immediately before MHB formation 
begins, with 2-APB or DMSO (Fig. 17A). The embryos were then allowed to 
develop to 24 ss and imaged using confocal microscopy in order to obtain single 
cell resolution images. We found that 2-APB treated embryos had abnormal MHB 
when compared to DMSO treated embryos (Fig. 17B-C’). We further quantified 
tissue and cell shape changes during MHB formation in the treatment groups (Fig. 
17D-E). Measurement of MHBC tissue angle showed a greater, more obtuse angle 
in 2-APB treated embryos (Fig. 17D and Fig. 18). This phenotype corresponds to 
an abnormal MHB phenotype, indicating insufficient tissue folding. Interestingly, 
the width of the neural tube at the MHBC, which represents the MHBC cell length, 
was also found to be greater in 2-APB treated embryos when compared to DMSO 
treated embryos (Fig. 17E and Fig. 18). Additional measurements including the 
width of the neural tube 40 µm away from the MHBC towards the hindbrain, the 
cell width, and the cell area, all remained unchanged in the 2-APB treated embryos 
(Fig. 18). Longer MHBC cells upon calcium inhibition suggest a role for calcium 
signaling in regulating cell length at the MHBC. 
In order to confirm the efficacy of 2-APB in decreasing cytosolic calcium levels, we 
used live imaging of calcium green, a calcium indicator dye that fluoresces green 
when bound to calcium molecules, enabling us to visualize calcium ‘spikes’ during 
development, as previously published by Fetcho, 2007; Reinhard et al., 1995. We 
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injected single-cell stage embryos with calcium green-1 dextran and treated 
embryos with DMSO or 2-APB to visualize calcium spikes using confocal 
microscopy (Fig. 19). We carried out this experiment at an early time point of 4 hpf 
since the fluorescent signals were undetectable at 24 ss (data not shown). A time-
lapse of confocal images for each embryo was taken to quantify the changes in 
fluorescence intensity. We found that approximately 2-3 cells in the enveloping 
layer of DMSO treated embryos distinctly fluoresced within this time frame in the 
region being imaged (Fig. 19A). Next, we treated the same embryo with 2-APB 
and again carried out time-lapse confocal imaging. We were unable to observe 
any obvious change in fluorescence in the embryo (Fig. 19B). To quantify these 
data, we took a ratio of the highest to lowest fluorescence intensity in a given cell 
area during the period of visualized calcium spikes. Comparison of this fold change 
in intensity showed that DMSO treated embryos had an average fold change of 
1.364 compared to a significantly reduced fold change of 1.2 in 2-APB treated 
embryos (Fig. 19C). We concluded that at 4 hpf, 2-APB decreases the amounts of 
cytosolic calcium in zebrafish embryos and is an important confirmation of the 
efficacy of 2-APB as previously published (Fetcho, 2007; Reinhard et al., 1995). 
Together, these data indicate that calcium is required for proper MHB formation in 
the zebrafish by regulation of MHBC cell length.  
Overactivation of NMII is rescued by decreasing cytosolic calcium 
It is known from previous studies that calcium signaling is involved in regulation of 
cell length in various cell culture models (Bramlage et al., 2001; White et al., 1993). 
It is also involved in regulation of NMII activity (Somlyo and Somlyo, 2003; Szent-
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Gyorgyi, 1975). Therefore, we hypothesized that calcium signals to NMII to 
regulate cell length during zebrafish MHB formation. In order to test this 
hypothesis, we utilized mypt1 morphant embryos and ER calcium inhibition. Mypt1 
knockdown results in overactivation of NMII and leads to abnormal cell shapes at 
the MHB with shorter and wider cells (Fig. 20A and Gutzman et al., 2015). We 
have also shown that reduction of cytosolic calcium by 2-APB results in abnormal 
MHB with longer MHBC cells (Fig. 17 and Fig. 20B). Therefore, we hypothesized 
that if calcium signals to NMII, then the cell shape phenotype of overactivation of 
NMII could be rescued by decreasing cytosolic calcium (Fig. 20C). We injected 
mypt1 morpholino into single cell stage embryos along with mGFP and treated 
them with 2-APB at 18 ss, followed by confocal imaging and cell shape analysis at 
24 ss (Fig. 20D-E). We found no difference in the MHB tissue angle in DMSO and 
2-APB treated mypt1 morphants (Fig. 20F and Fig. 21). In fact, the angle 
phenotype observed with both treatments was the same as what we found in 
mypt1 morphants previously (Chapter 2, Figs. 11-13) However, the length of the 
cells at the MHBC in 2-APB treated mypt1 morphants was significantly longer 
compared to DMSO treated mypt1 morphants (Fig. 20G and Fig. 21). This was the 
only parameter that was significantly different in our quantification of 
morphogenetic changes in tissue and cell shape. We did not find any difference in 
cell length 40 µm away from the MHB towards the hindbrain, cell width, and cell 
area (Fig. 20F-G and Fig. 21). These data indicate a rescue of the MHBC cell 
length phenotype, from shorter MHBC cells seen in the mypt1 morphants to 
comparatively longer MHBC cells upon calcium inhibition. Although the cell length 
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was rescued, the MHB angle was still abnormally large because the cell width was 
not rescued. We know from our previous work that either cell length or cell width 
abnormalities can result in abnormal tissue angle, which explains why a rescue of 
only cell length does not rescue the MHB tissue angle (Chapter 2, Figs. 11-13). 
Thus, in mypt1 morphants, MHBC cell length is the sole cell shape parameter 
measured that is rescued by inhibition of cytosolic calcium.  
To further test for calcium as an upstream signal regulating NMII, we hypothesized 
that inhibition of calcium ER release by 2-APB would result in reduced amounts of 
phosphorylated MLC (pMLC), which would be an indication of activation of NMII 
molecules. However, Western blotting determined no significant changes in pMLC 
levels (Fig. 22A). We have previously seen that knockdown of mypt1 in zebrafish 
brain leads to increased quantities of pMLC (Gutzman and Sive, 2010). In order to 
take a different approach, we hypothesized that mypt1 morphants with increased 
pMLC levels would show a visible reduction in the pMLC amount when treated with 
2-APB. Surprisingly, we did not find any changes in pMLC levels here as well (Fig. 
22B). This could be attributed to the small size of the pMLC protein, making the 
change undetectable on blots. Therefore, the role for calcium signaling in 
regulation of pMLC requires further investigation. From these experiments, we 
conclude that calcium signaling is required for proper shortening of MHBC cells 
during this morphogenetic process.  
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D. DISCUSSION 
Calcium regulates cell length during MHB formation  
Calcium ions can enter the cell from the external environment through calcium 
channels on the cell membrane, or from intracellular storage organelles, and affect 
cytosolic calcium concentration (Westfall et al., 2003). One major source of 
intracellular calcium is the ER, where opening of calcium channels are regulated 
by IP3R (Berridge et al., 2003; Berridge et al., 2000; Slusarski and Pelegri, 2007). 
Calcium signaling has been previously studied for its role in regulating cell shape 
in platelet and endothelial cells (Moore et al., 1998; Porter et al., 2003). Here, our 
investigation of the role of calcium signaling in zebrafish MHB formation identified 
an important role for calcium in cellular morphogenesis. We found that calcium is 
required for proper MHB formation and has a specific role in cell shortening at the 
MHBC (Fig. 17). Regulation of cell shortening by calcium waves has been 
previously seen in adult cardiac myocytes in vitro (Bramlage et al., 2001). For the 
first time, we show calcium mediated regulation of cell length during 
morphogenesis in a live vertebrate model. Additionally, this result draws a potential 
important correlation to our previous finding of the role of NMIIA in regulating cell 
length during zebrafish MHB formation (Gutzman et al., 2015). Both inhibition of 
ER calcium release and NMIIA knockdown show the same MHB cell shape 
phenotype, possibly suggesting that both molecules may be functioning as part of 
the same signaling pathway (Fig. 23B).  
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Calcium regulates cell length during MHB formation through NMII 
Although there have been studies involving calcium mediated regulation of NMII 
activity, these studies have been mostly done in cell culture (Martinsen et al., 2013; 
Watanabe et al., 2001). Here, we show that the cell length phenotype in mypt1 
morphants, with overactive NMII, is rescued when calcium release from the ER is 
inhibited, suggesting an important correlation between the two signaling 
molecules. Interestingly, we observed that the MHB tissue angle is not rescued 
along with the cell length phenotype. A possible explanation could be that the cell 
width phenotype of mypt1 morphants is not rescued and we know that cell width 
is also a contributor to normal MHB tissue angle (Chapter 2, Gutzman et al., 2015). 
Myosin phosphatase dephosphorylates the MLC for both NMII homologs, NMIIA 
and NMIIB. Hence, knockdown of mypt1 inhibits the action of myosin phosphatase 
for both class II non-muscle myosins, resulting in overactive NMIIA and NMIIB 
(Hartshorne et al., 2004). Rescue of only the cell length phenotype of mypt1 
knockdown by calcium inhibition, leads us to hypothesize that calcium specifically 
regulates NMIIA. Thus, we hypothesize that both calcium and NMIIA function in 
the same signaling pathway through intermediate signaling molecules (Fig. 23B).  
Calcium, being an inorganic molecule, typically interacts with calcium binding 
proteins to signal to downstream molecules such as ones that make up the 
cytoskeleton. Calmodulin is a calcium binding protein and has been shown to be 
required for morphogenesis in yeast (Kraus et al., 2005; Paranjape et al., 1990). 
Calcium, calmodulin and myosin have also been studied together to regulate cell 
shape change in Euglena (Lonergan, 1984; Lonergan, 1985). Additionally, it has 
97 
 
 
 
been shown that various CAM kinase II isoforms are expressed in the zebrafish 
brain during early development, making calmodulin a possible candidate in 
zebrafish MHB development (Rothschild et al., 2007). The activation of NMII is 
carried out by various kinases such as the myosin light chain kinase (MLCK), also 
a potential molecule in the calcium signaling pathway due to its involvement in 
various developmental morphogenetic processes (Ewald et al., 2008). A proposed 
model for the regulation of NMII activity through the calcium signaling pathway is 
shown in figure 23B. The precise molecular interactions between these molecules 
are yet to be determined and serve to be the basis of future experiments.   
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Figure 17. Calcium regulates cell length during MHB formation. (A) 
Experimental procedure. Single cell stage zebrafish embryos were injected with 
mGFP, treated with 0.1% DMSO or 100 µM 2-APB at 18 ss, and imaged at 24 ss. 
(B-C) Confocal images of treated embryos as indicated at 24 ss. (B’-C’) 
Magnifications of images in B-C showing shape outlines of cells marked with 
yellow asterisks. Arrowheads indicate MHBC. (D) Comparison of average tissue 
angle at the MHBC and (E) average width of the neural tube at the MHBC (see 
lines in B,C). Mann-Whitney U-test was performed to determine significance 
between control and test groups. Asterisk indicates p< 0.05. DMSO, n=9;  2-APB, 
n=8. Error bars are ±s.e.m.  
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Figure 18. Quantification of cell shape parameters in 2-APB treated embryos.  
(A) Neuroepithelial MHB tissue angle, (B) Width of the neural tube at the MHBC or 
cell length at th MHBC, (C) Width of the neural tube 40 µm away from the MHBC 
or cell length 40 µm away from the MHBC towards the hindbrain region, (D) Cell 
width and (E) Cell area. Mann-Whitney U-test was performed to determine 
significance between control and test groups. Asterisk represents p< 0.05. For 
angle and cell length measurements, n=12; for cell width and area measurements, 
n=7. Error bars are ±s.e.m.  
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Figure 19. Calcium green-1 dextran imaging confirms inhibition of 
intracellular calcium levels by 2-APB. (A-B) Timelapse confocal images of 
zebrafish embryos injected with the calcium indicator and treated and imaged at 4 
hpf with (A) 0.1% DMSO and (B) 100 µM 2-APB. Timelapse was done once every 
10 seconds for 10 minutes. Arrows and arrowheads indicate rapidly changing 
calcium dynamics in two different cells. (C) Quantification of change in 
fluorescence intensity. Mann-Whitney U-test was performed to determine 
significance between control and test groups. Asterisk indicates p<0.001. n=6 
each. Error bars are ±s.e.m. 
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Figure 20. Inhibition of cytosolic calcium rescues cell length phenotype of 
overactivation of NMII. (A-C) Schematic of experimental hypothesis. (A) Mypt1 
knockdown results in overactivation of myosin light chain and abnormal MHB with 
shorter and wider MHB cells. (B) Inhibition of calcium release from ER by 2-APB 
results in abnormal MHB with longer MHBC cells. (C) IF: calcium signals to NMII, 
THEN: inhibition of calcium release in mypt1 knockdown embryo would rescue 
MHB cell shape phenotype. (D-E) Confocal images of 24 ss embryos injected with 
mGFP and mypt1 morpholino and treated with (D) 0.1% DMSO and (E) 100 µM 2-
APB at 18 ss. (D’-E’) Magnified images from D-E. Arrowheads indicate MHBC. (F-
I) Quantification of cell shape changes occuring during MHB formation- (F) MHBC 
tissue angle, (G) width of the neural tube at the MHBC, (H) width of the neural tube 
40 µm away from the MHBC and (I) cell width. Only width of the neural tube at the 
MHBC (G) is different between the two treatment groups. Mann-Whitney U-test 
was performed to determine significance between control and test groups. Asterisk 
indicates p<0.01. For angle and length measurements, DMSO, n=13; 2-APB, 
n=17; for cell width measurement, n=13 embryos each. Error bars are ±s.e.m.    
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Figure 21. Quantification of cell shape parameters in 2-APB treated mypt1 
morphant embryos. Quantification of cell shape parameters in 2-APB treated 
mypt1 morphant embryos. (A) Neuroepithelial MHB tissue angle, (B) Width of the 
neural tube at the MHBC or cell length at the MHBC, (C) Width of the neural tube 
40 µm away from the MHBC or cell length 40 µm away from the MHBC towards 
the hindbrain region, (D) Cell width and (E) Cell area. Mann-Whitney U-test was 
performed to determine significance between control and test groups. Asterisk 
indicates p<0.01. For angle and length measurements, DMSO, n=13; 2-APB, 
n=17. For cell width and area measurement, n=13 embryos each. Error bars are 
±s.e.m.    
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Figure 22. pMLC Western blotting. (A) Western blotting for pMLC using wild-
type embryonic brain tissue treated with DMSO or 2-APB showed no difference 
in phosphorylation of MLC. Graph represents quantification of Western blotting 
data and is an average of six independent experiments. Mann-Whitney U-test 
was performed to determine significance between control and test groups. Error 
bar is ±s.e.m. (B) Western blotting for pMLC using mypt1 morphants treated with 
DMSO or 2-APB also showed no difference in phosphorylation levels of NMII. 
Hdac1 was used as loading control. 
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Figure 23. Summary and hypothesized model of the calcium signaling 
pathway regulating NMII. (A) Diagram representing a zebrafish embryonic brain 
viewed dorsally with magnified view of the MHB and a simplified model depicting 
normal MHB cell shapes at 24 ss. Control or wild-type embryos have a normal 
MHB tissue angle of 100 degrees while decrease in cytosolic calcium leads to 
abnormal MHB formation due to MHBC cells not shortening properly. Figure 
adapted from Gutzman et al., 2015. (B) Diagram representing the hypothesis that 
the calcium signaling pathway via calmodulin and myosin light chain kinase, 
signals to activate NMIIA, regulating cell length during zebrafish MHB 
morphogenesis. Red arrows indicate hypothesized interaction. 
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CHAPTER 4 
CONCLUSIONS AND FUTURE DIRECTIONS 
A. CONCLUSIONS 
The primary aim of this project was to characterize the morphogenetic events 
occurring during midbrain-hindbrain boundary (MHB) formation using zebrafish as 
a model, and further understand and elucidate the mechanisms responsible for 
this epithelial morphogenetic process. We first characterized the neuroepithelial 
cell shape changes that occur during this process (Chapter 2, Fig. 10). We 
concentrated on a shorter time frame when the MHB first folds, between 18 ss and 
24 ss. We found that the neuroepithelial MHB tissue angle decreases over time, 
depicting the formation of the constriction. During this process, the MHB cells 
shorten and narrow to enable the folding of the tissue, resulting in the formation of 
a proper MHB with a deep MHB constriction (MHBC).  
NMIIA and NMIIB differentially regulate zebrafish MHB morphogenesis 
We hypothesized that non-muscle myosin II (NMII) proteins are required for 
zebrafish MHB formation and we tested this by gene knockdown and consequent 
confocal microscopic study and analysis. We determined a novel role for NMIIA 
and NMIIB in regulating cell shape during zebrafish MHB morphogenesis. We 
found that myh9b, a zebrafish ohnolog for the human MYH9 gene that encodes for 
NMIIA, is responsible for the shortening of cells at the MHBC and myh10, encoding 
for NMIIB, is required for cells throughout the MHB region to narrow (Chapter 2, 
Figs. 12-13). The identification of a differential function for NMIIA and NMIIB in the 
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formation of the zebrafish MHB led to the question of how they carry out these 
distinct functions. We found that both proteins are not differentially localized within 
the MHB but we observed differential disruption in actin distribution upon 
knockdown of NMIIA and NMIIB (Chapter 2, Fig. 14).  
Calcium regulates zebrafish MHB formation  
We also hypothesized that calcium signaling plays a role in MHB development and 
is an upstream regulator of NMII. To test the first hypothesis, we employed the use 
of 2-APB, a drug that inhibits the release of calcium from the endoplasmic 
reticulum (ER). We found that depletion of cytosolic calcium resulted in an 
abnormal MHB angle and longer MHBC cells, showing that calcium is required for 
zebrafish MHB formation (Chapter 3, Fig. 17). Interestingly, this phenotype is 
similar to the phenotype seen with the knockdown of myh9b (Chapter 2, Figs. 11-
12), suggesting the possible involvement of calcium and NMII within the same 
signaling pathway in MHB formation.  
We further hypothesized that calcium signals to activate NMII. We had previously 
determined that both NMIIA knockdown and cytosolic calcium inhibition result in 
abnormal MHB with longer MHBC cells. We had also shown that knockdown of 
mypt1, which corresponds to overactivation of NMII, also results in abnormal MHB 
with shorter and wider MHB cells. Thus, if calcium signals to NMII, then 
overactivation of NMII would be rescued by inhibition of cytosolic calcium. We 
found that only the MHBC cell length phenotype seen in mypt1 morphants was 
rescued upon 2-APB treatment (Chapter 3, Fig. 19). Since we have also 
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determined that cell length is regulated by NMIIA (Chapter 2, Fig. 11), we further 
hypothesize that calcium differentially signals to NMIIA, and not NMIIB.   
B. FUTURE DIRECTIONS 
How do NMIIA and NMIIB function differentially? 
Although we have discovered distinct functions for NMIIA and NMIIB in zebrafish 
MHB morphogenesis, the mechanisms by which they carry out their differential 
function remains unknown. The following questions address different hypotheses 
regarding how NMIIA and NMIIB may function differently to regulate cell shape and 
outline future experiments to test each of these hypotheses.    
 Are NMIIA and NMIIB filaments oriented differentially?  
Since we did not observe any difference in localization of NMII isoforms in the MHB 
region, it is possible that the NMIIA and NMIIB fibers are oriented differentially. We 
hypothesize that NMIIA fibers are oriented longitudinally, along the apical-basal 
axis to regulate cell length, while NMIIB is oriented perpendicular to the apical-
basal axis of the cells, regulating cell width. Total internal reflection fluorescence 
microscopy (TIRF) is a recent advancement in the field of microscopy, which 
allows visualization at the level of single molecules and is dynamic, allowing us to 
see the active processes going on inside living systems (Sako et al., 2000). While 
the movement of NMII isoforms has been studied in a similar way using TIRF in 
cell culture, visualization of single molecules in live organisms such as C. elegans, 
medaka and zebrafish has also been made possible recently (Beach et al., 2014; 
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Wang et al., 2010). To test our hypothesis, we could fluorescently tag NMIIA and 
NMIIB to visualize the movement of the molecules along actin fibers using TIRF. 
With respect to the cell shape changes occurring during zebrafish MHB 
morphogenesis, we would expect to see NMIIA fibers move longitudinally along 
the apical-basal axis and NMIIB molecules to move in the perpendicular direction. 
This would provide an answer to the question of how NMIIA and NMIIB function 
differentially during MHB formation in the zebrafish.        
 Can NMII function be regulated by molecules that differentially 
phosphorylate the MLC of NMIIA and NMIIB? 
The MLC of NMII is known to be phosphorylated by various kinases, two of the 
most studied are Rho kinase and myosin light chain kinase (MLCK) (Betapudi, 
2014). Since we have already determined that calcium regulates only MHBC cell 
length, and not cell width, which corresponds to findings from NMIIA knockdown 
phenotype (Chapter 3, Fig. 17), we hypothesize that the calcium-calmodulin 
dependent MLCK phosphorylates NMIIA, while Rho kinase phosphorylates NMIIB. 
To test this hypothesis, activation of MLCK can be inhibited using a 
pharmacological drug, ML-7 (Saitoh et al., 1987), followed by a co-
immunoprecipitation (co-IP) assay for pMLC with NMIIA and NMIIB, through 
Western blotting analysis. We would expect to see reduced amounts of NMIIA in 
ML-7 treated embryos, but no difference in NMIIB abundance. This would suggest 
that MLCK phosphorylates NMIIA, but not NMIIB. Similarly, we would inhibit Rho 
kinase using its specific inhibitor Y27632 (Ishizaki et al., 2000), and carry out a co-
IP and Western blot analysis of pMLC with NMIIA or NMIIB. We would expect to 
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see reduced amounts of NMIIB in Rho inhibited embryos, but no reduction in 
NMIIA levels. This will suggest that Rho preferentially signals to phosphorylate 
NMIIB.   
 Can differential regulation of NMII isoforms occur through 
phosphorylation of the myosin heavy chain? 
The NMII heavy chain has multiple phosphorylation sites, some of which are 
specific to individual homologs. The NMIIA heavy chain has a ser-1943 site that 
can be phosphorylated by casein kinase II. Absence of this phosphorylation 
prevents its binding to s100A4, a member of the s100 family of calcium binding 
proteins. This phosphorylation event results in inhibition of filament assembly, 
disrupting its regular function (Vicente-Manzanares et al., 2009). The NMIIB heavy 
chain also has a ser-1937 site phosphorylated by protein kinase C (PKC), which 
is responsible for filament assembly (Vicente-Manzanares et al., 2009). These 
distinct sites in the two homologs phosphorylated by different enzymes, but 
carrying out the same function could indicate a differential regulation of the two 
heavy chains. Using specific antibodies against each of these phosphorylated sites 
on the heavy chains, we could carry out immunostaining to identify differences in 
NMIIA and NMIIB protein localization. We would expect to see differential 
localization of the phosphorylated forms of the two proteins which would help us 
explain their respective differential functions.   
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How does the calcium signaling pathway regulate zebrafish MHB 
morphogenesis? 
In this research, we have discovered a novel role for calcium signaling in regulating 
cell length during zebrafish MHB morphogenesis. It remains to be determined if 
and how calcium signaling regulates NMII during this process. The following 
questions address this, and will help us to determine the specific pathway through 
which NMII is regulated. 
 How can we confirm the efficacy of 2-APB at 24 ss? 
We confirmed the efficacy of 2-APB in depleting cytosolic calcium levels by calcium 
green-1 dextran, a calcium indicator (Chapter 3). However, this experiment was 
carried out at 4 hpf, while all our experiments have been done in the time range of 
18-24 ss. Since the fluorescence of calcium green-1 dextran does not give a good 
signal at 24 ss, a different calcium indicator is required for better confirmation. This 
can be done by using a genetically encoded calcium indicator, GCaMP. GCaMP6, 
one of the recent sensitive and efficient calcium indicators for live visualization of 
calcium, has been utilized for imaging in zebrafish (Chen et al., 2013). We have 
obtained plasmid constructs of the GCaMP6 gene (a kind gift from Phillip Keller, 
Howard Hughes Medical Institute) which can be utilized to synthesize mRNA and 
inject it into single cell embryos, followed by imaging at a more relevant time point 
to test for the efficacy of 2-APB. Time-lapse confocal imaging of 2-APB treated 
embryos, upon comparison with control DMSO treated embryos would reveal 
decreased amounts of fluorescent calcium, or loss of visualization of excitatory 
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cells, and this will confirm the efficacy of 2-APB at 24 ss, the time-point at which 
our experiments were carried out.    
 Do we need additional confirmation of the role of calcium in zebrafish 
MHB development? 
Signaling pathways involving calcium are complicated and difficult to study 
because, unlike other signaling molecules that are products of cellular transcription 
and translation, calcium is an inorganic diffusible molecule not synthesized by the 
body. Studies on calcium signaling typically involve manipulation of its 
concentration through pharmacological drugs that either increase or decrease its 
cytosolic levels. Use of these drugs can result in variable effects in vivo versus in 
vitro and this makes it important to test the functionality of the drug within in vivo 
systems using tools such as the GCaMP6 calcium indicator described above. 
Further, due to the nature of the drugs and variability in the efficacy of the drugs in 
live organisms, it is important that more than one drug be used to confirm the 
findings.  
It is established that a major source of cytosolic calcium is by its release from the 
ER and from previously published studies and our own findings, we know that 
calcium levels can be regulated by manipulation of the IP3 receptors (Westfall et 
al., 2003). Apart from 2-APB, other pharmacological drugs such as thapsigargin, 
xestospongin C, and calcium ionophore A23187, which either increase or 
decrease intracellular calcium levels, can be used to additionally confirm the 
identified role of calcium in MHB morphogenesis (Westfall et al., 2003). 
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Xestospongin C is similar to 2-APB, and inhibits IP3R, preventing the opening of 
the calcium channels on the ER membrane (Gafni et al., 1997; Westfall et al., 
2003). Thapsigargin and ionophore A23187 work to increase the cytosolic calcium 
levels. Treatment with thapsigargin inhibits the calcium-ATPase pump on ER 
membranes, depleting calcium from the ER and resulting in increase in cytosolic 
calcium. It also blocks the calcium pumps on the cell membrane, increasing influx 
of calcium from outside the cell. However, it is important to note that once the drug 
is washed out, the effect of the drug is reversible (Kluver et al., 2011; Westfall et 
al., 2003). Calcium ionophore A23187 allows calcium from extracellular sources to 
enter the cell, also causing an increase in intracellular calcium concentration (Lee 
et al., 1999; Shu et al., 2007). Embryos can be treated with each of these drugs at 
18 ss and imaged on the confocal microscope at 24 ss to quantify cell shape 
changes. We would expect to see abnormal MHB tissue angle in each of the 
treatment groups. Depending on the drug treatment we would predict different 
effects on MHB cell shape. Xestospongin C treated embryos would show longer 
MHBC cells while thapsigargin and ionophore treated embryos would show shorter 
MHBC cells than in control. These experiments would help us determine whether 
calcium has a role in regulating cell length during zebrafish MHB formation.   
 Is calcium an upstream regulator of NMII during zebrafish MHB 
formation? 
In order to determine if NMII is regulated by calcium upstream, we depleted 
cytosolic calcium by 2-APB treatment and carried out a Western blot to determine 
changes in pMLC levels (Chapter 3, Fig. S7). However, we did not find any 
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observable reduction in pMLC abundance in wild-type or mypt1 morphant 
embryos. MLC is a relatively small protein of 20 KDa size with low protein 
abundance and it is possible that the decrease in protein level is not detectable by 
Western blot. However, a small change in the amount of pMLC may still be 
sufficient to cause significant changes in morphogenesis. As an alternative, 
thapsigargin and calcium ionophore A23187 are both pharmacological drugs that 
increase the amount of intracellular calcium, which could potentially improve 
detection of changes in pMLC levels. Thus, we would expect to see an increase in 
pMLC abundance in thapsigargin or ionophore treated embryos by Western 
blotting. This would help us in determining if calcium signals to NMII.     
 Does calcium differentially signal to NMIIA? 
The finding that calcium inhibition results in longer MHBC cells, along with rescue 
of only the cell length phenotype in mypt1 morphants upon 2-APB treatment, led 
us to hypothesize that calcium differentially signals to NMIIA. To test this 
hypothesis, we would treat 18 ss embryos with 2-APB (or an alternate drug that 
proves to be more efficient) and carry out a co-immunoprecipitation, by assaying 
for pMLC and Western blotting for NMIIA and NMIIB. We would expect to detect 
reduced amounts of NMIIA in the blot and no difference in levels of NMIIB. This 
reduction in pMLC-NMIIA quantity upon inhibition of cytosolic calcium would 
suggest that calcium signals differentially to NMIIA.     
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 What are the intermediate molecules in the calcium-NMII signaling 
pathway? 
We hypothesize that calmodulin and myosin light chain kinase (MLCK) mediate 
the interaction of calcium with NMII (Chapter 3, fig. 20). Calmodulin is a calcium 
binding protein that plays a role in yeast cell morphogenesis (Kraus et al., 2005; 
Paranjape et al., 1990). CAM kinase II, a calcium/calmodulin-dependent protein 
kinase, is important in developmental events such as cardiac and fin 
morphogenesis (Rothschild et al., 2009). It is also expressed in the brain during 
early development and is required for zebrafish brain morphogenesis (Hsu and 
Tseng, 2010; Senga et al., 2013). This makes calmodulin a possible candidate 
required for zebrafish MHB morphogenesis. Further, it has been shown that 
calcium/calmodulin-dependent MLCK regulates NMII in renal collecting ducts 
(Chou et al., 2004). Calmodulin 1a (calm1a) is specifically expressed at the MHB 
during time points of interest and hence would be the ideal candidate (Friedberg 
and Taliaferro, 2005; Thisse, 2001). The role of calmodulin can be studied by 
morpholino mediated knockdown and mutants generated by targeted gene editing 
of calm1a, followed by analysis of MHB cell shapes in 24 ss embryos. We would 
expect to see longer MHBC cells in these morphants and knock out mutants, which 
would result in wider MHB tissue angle, representing an abnormal MHB.   
In order to test the role of MLCK in MHB morphogenesis, we could inhibit it with 
the pharmacological inhibitor, ML-7 (Saitoh et al., 1987). ML-7 inhibits the 
activation of MLCK, preventing its functioning. Alternately, a dominant-negative 
construct for MLCK can also be used to prevent the normal functioning of the 
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kinase (Shimizu et al., 2006). Embryos treated with either ML-7 or injected with the 
dominant-negative MLCK could be analyzed for cell shapes at 24 ss using confocal 
microscopy. If MLCK phosphorylates NMIIA, we would expect to see abnormal 
MHB formation with longer MHBC cells. Additionally, a co-immunoprecipitation can 
be done, by pulling down pMLC and Western blotting for NMIIA and NMIIB, in 
conditions where MLCK is inhibited. We would expect to see a decrease in the 
amount of NMIIA, and not NMIIB in the test group of embryos when compared to 
control. A decrease in amount of pMLC-NMIIA upon inhibition of MLCK would 
indicate that MLCK signals to NMIIA. This would allow us to conclude if our 
hypothesis that MLCK differentially activates NMIIA is correct.   
What are the signaling pathways regulating zebrafish MHB 
morphogenesis? 
Any morphogenetic event during development is a complex process involving 
multiple signaling pathways. Hence, in order to tease out these pathways, a more 
global approach is required. A proteomic mass spectrometric analysis of 
embryonic brain tissue before and during MHB formation, and comparison of 
changes in protein levels would help identify molecules that may regulate MHB 
formation. It may also lead to discovery of novel molecules involved in this process. 
After identification of potential molecules and signaling pathways, we could 
specifically investigate individual downstream pathways to identify their roles in 
zebrafish MHB formation. 
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Thus, in this thesis, we characterized the cell shape changes occurring during 
zebrafish MHB formation and discovered an important role for NMII proteins in this 
morphogenetic process. We found that NMIIA regulates MHBC cell length and 
NMIIB regulates MHB cell width. We also determined that calcium is required for 
MHB morphogenesis, by its regulation of MHBC cell length. We further discovered 
that only the MHBC cell length phenotype of NMII overactivation is rescued by 
inhibition of calcium, which suggests possible differential regulation of NMIIA by 
calcium signaling. However, further investigation is required to elucidate how NMII 
proteins function differentially. These findings are likely to be similar in other 
morphogenetic events and will help expand our knowledge of the molecular 
mechanisms behind other developmental processes as well.          
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